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1  Summary 
Conjugation of ubiquitin-like proteins (UBLs) to target proteins involves an 
enzymatic cascade. The best-studied member of the UBL family is ubiquitin. In 
addition to ubiquitin, eukaryotes possess several other UBLs such as SUMO and 
Rub1/Nedd8. Interestingly, a group of bacterial and archaeal sulphur carriers 
resemble UBLs structurally, however, these proteins do not form protein 
conjugates. The eukaryotic protein Urm1 is related to these bacterial sulphur 
carriers, but also shares functional features of eukaryotic UBLs. Urm1 can act as a 
sulphur carrier for the thiolation of tRNAs, but also as a protein modifier. Both 
reactions require the E1-like enzyme Uba4. To date, the only described Urm1 
substrate in S. cerevisiae is the thioredoxin peroxidase Ahp1. Moreover, it has 
been shown that the double-glycine motif of Urm1 is required to modify Ahp1, and 
that Urm1 is covalently attached to a lysine residue of Ahp1. However, until now 
the functional role of protein urmylation remains unclear. 
 To gain insights into the function of Urm1 as a posttranslational protein 
modifier, we use tagged Urm1 to isolate Urm1-substrates and to identify them by 
mass spectrometry. In this study, we identified putative Urm1-substrates that are 
part of various cellular processes. In particular, the zinc-responsive activator 
protein 1 (Zap1), a master zinc regulator in S. cerevisiae, emerges as a novel 
Urm1-substrate. Not only does the transcription factor Zap1 regulate numerous 
genes in involved, inter alia, in zinc homeostasis, ROS defense, sulfate 
metabolism, phospholipid synthesis, but also ZAP1 transcription itself. Additionally, 
Zap1 acts as a zinc sensor by binding zinc ions directly through two zinc fingers 
(ZFs), which are located at the transactivation domains (ADs) AD1 and AD2. Here, 
we demonstrate that Zap1 urmylation is restricted to the cytoplasm. Zap1 is 
urmylated at the lysine residue K871. Intriguingly, lack of Zap1 urmylation seems 
to promote rapid ubiquitin-dependent degradation, whereas Zap1 is less 
susceptible to degradation in presence of the urmylation machinery. As a 
consequence, Zap1 urmylation positively influences Zap1 transcriptional activity 
and its downstream target Zrt1 in vivo. Thus, a possible function of Zap1 
urmylation could be to antagonize Zap1 ubiquitination and its subsequent 
ubiquitin-proteasome system (UPS)-mediated degradation. 
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2  Introduction 
Cellular processes require intricate and multilayered cellular regulation to maintain 
cellular homeostasis in response to diverse intracellular or extracellular changes. 
Several cellular strategies such as the regulation of mRNA transcription, mRNA 
processing, RNA splicing and translational control are employed to induce 
manifold cellular alterations. Additionally, proteins can undergo a variety of post-
translational modifications (PTMs) that can comprise in the conjugation of 
additional moieties to functional groups (e.g. acetylation, alkylation, methylation, 
lipidation and glycosylation) or by adding a new functional group to proteins (e.g. 
phosphorylation). PTMs affect the physical properties of proteins, which in term 
expand their cellular function and changes the protein dynamics. Proteins are not 
only modified by small molecules but by entire proteins belonging to the ubiquitin 
family of modifiers. Ubiquitin-like proteins (UBLs) like ubiquitin, Smt3 (SUMO), 
Atg8, Rub1 (NEDD8), Hub1, Atg8, Atg12, UFM1, ISG15, FAT10, FUB1, and Urm1 
share common features such as the globular β-grasp fold lending UBLs a globular 
tertiary structure (Hochstrasser, 2000; 2009). Though functionally diverse, the 
principles of substrate-conjugation of UBLs resemble the mechanism of the best-
studied UBL member ubiquitin (Fig. 2-1). Prior to the conjugation to target proteins,  
 
Fig. 2-1. General ized conjugation system of ubiquit in-l ike proteins (UBLs). 
Activation and conjugation of UBLs usually require an enzymatic cascade involving the E1 activating enzyme, 
the E2 conjugating enzyme and in some cases an E3 ligase. The C-terminus of the activated UBLs forms an 
isopeptide bond to the ε-amino group of the target acceptor residue. The UBL-protein modification is 
reversible through isopeptidases such as ubiquitin-like protein-processing enzymes (ULPs) or deubiquitinating 
enzymes (DUBs). Adopted from Hochstrasser, 2000. 
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ubiquitin and UBLs undergo an enzymatic cascade. First, the C- carboxyl group of 
UBLs’ terminal double-glycine motif (GG-motif) is activated by adenylation via the 
activating enzyme (E1). The E1 attacks the carboxyl-AMP of the UBL via its thiol 
group resulting in the formation of an UBL-E1 thioester. The activated UBL is 
transformed from the E1 to the cysteine side chain of the conjugating enzyme 
(E2), from which the UBL forms a ε-amino bond between the C-terminal 
carboxylate of the modifier and the lysine side chain of the conjugate. E3 protein 
ligases are required for the final transfer of the UBL to the substrate. E3s either 
allosterically activate E2s and/or function as adaptors mediating the UBL-substrate 
conjugation (e.g. RING E3 ligases). Alternatively, the E2-bound UBL is transferred 
to the E3 via a thioester bond before the UBL is lastly ligated to the substrate (e.g. 
HECT E3 ligases). 
UBL substrates can be either modified by one UBL moiety or by multiple 
single UBL moieties at different lysine residues (Geoffrey & Hay, 2009). However, 
UBLs such as ubiquitin, SUMO, Rub1 (Nedd8) and ISG15 are able to modify 
target proteins multiple times at the same lysine residue by forming polyUBL-
chains based on either linear or branched linkages that can contain the same UBL 
or a mixture of different UBL moieties (Leidecker et al., 2012; Singh et al., 2012; 
Ciechanover & Stanhill, 2014; and Fan et al., 2015). Although the function of 
mixed UBL-chains are not fully understood, chain formation of ubiquitin and its 
functional implication has been widely studied (Chau et al., 1989; and Pickart, 
2001). The best-studied UBL of the UBL family ubiquitin contains seven lysine 
residues, which all are susceptible to polyubiquitin chain formation (Xu et al., 
2009). While polyubiquitination on K48 guides the target protein to the 
proteasomal degradation, K63-linked polyubiquitin chains are involved in non-
proteolytic processes such as endocytosis, translation, DNA repair and signal 
transduction (Chau et al., 1989; Spence et al., 1995; Kerscher et al., 2006; Chen & 
Sun, 2009; Hochstrasser, 2009; and Rape, 2010). However, the function of K6-, 
K27-, K29- and K33-linked polyubiquitination is less known. 
Protein modifications are able to play diverse roles in cellular processes 
(Fig. 2-2). For instance, UBL conjugation to a target protein can provide an 
additional binding site (Fig. 2-2A). The ubiquitin-binding domain (UBD)-containing 
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proteasomal receptors such as Rpn13 recognize and strongly bind to polyubiquitin 
chains that are attached to substrates (Husnjak et al., 2008). Alternatively, UBL 
conjugation is able to cause conformational changes on the target protein that 
facilities binding to another protein (Fig. 2-2B). UBL modifications can also act as a 
molecular switch. The modification of different UBLs to the target protein can result 
in different fates of the UBL modified protein (Fig. 2-2C). These modifications can 
happen at the same attachment site and can be mutually exclusive. The 
proliferating cell nuclear antigen (PCNA), a DNA clamp that is essential for DNA 
replication and recombination, is modulated by the modification of SUMO or 
ubiquitin, which recruits distinct cofactors to the modified PCNA (Hoege et al., 
2002; Pfander et al., 2005; Moldovan et al., 2006 and Moldovan et al., 2007). 
Another mechanism of UBL conjugation is the inhibition of protein-protein 
interaction as a result of UBL modification of the target protein (Fig. 2-2D). For  
 
 
Fig. 2-2. General functions of UBLs. 
(A) UBL conjugation to target protein improves protein-protein interaction by providing an additional binding 
site. (B) UBL conjugation enhances protein-protein interaction by triggering a conformational change of the 
UBL-modified protein. (C) Modification by different UBLs acts like a switch enabling the modified protein to 
interact with different proteins. (D) UBL conjugation inhibits the interaction with a potential interaction partner. 
Adopted from Hochstrasser, 2009. 
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example, SUMOylation of the transcription factor specificity protein 1 (Sp1) by 
SUMO-2/3 prevents the interaction of Sp1 with the acetyl transferase p300 during 
embryonic development (Gong et al., 2014). 
Similar to many posttranslational modifications, modifications of proteins by UBLs 
are mostly reversible (Wilkinson, 1997; Nijman et al., 2005; and Reyes-Turcu et 
al., 2009). A set of proteases of Deubiquitinating enzymes (DUBs) and ubiquitin-
like protein-processing enzymes (ULPs) are capable of removing UBLs from their 
target proteins. In addition, most UBLs are synthesized as precursors with one or 
more amino acids following the GG-motif. The free GG-motif at the C-terminal end 
of UBLs is essential for protein conjugation. Therefore the precursors are 
processed by DUBs and ULPs, which remove the amino acids C-terminal of the 
GG-motif. Ubiquitin, for instance, is synthesized as precursor consisting of either a 
single ubiquitin moiety fused to ribosomal proteins or as polyubiquitin chains, 
which both require DUBs to yield processed ubiquitin monomers (Wiborg et al., 
1985; Baker & Board, 1987; and Ozkaynak et al., 1987). In summary, DUBs are 
both responsible for the processing of UBL precursors and capable of 
antagonizing protein modification by UBLs. They are important regulators of the 
free UBL pool and regulate the amount of UBL-modified proteins and thus 
influence the fate of the target proteins (Nijman et al., 2005). 
 
2.1  The ubiquit in-related modif ier Urm1 
Since the discovery of the first prokaryotic UBLs like the bacterial ThiS and MoaD, 
it has become apparent that UBLs and their activation via an E1-like enzyme 
seems to be evolutionary highly conserved across the domains of life 
(Rajagopalan, 1997; Taylor et al., 1998; Iyer et al., 2006; and Maupin-Furlow, 
2013). MoaD and ThiS structurally resemble the ubiquitin fold of other UBLs, as 
both have a β-grasp fold and a functional GG-motif (Rajagopalan, 1997; Taylor et 
al., 1998; Lake et al., 2001; Rudolph et al., 2001; and Wang et al., 2001). In 2000, 
the eukaryotic ubiquitin-related modifier 1 (Urm1) was discovered by a PSI BLAST 
search using the sequences of ThiS and MoaD, which were analyzed for proteins 
with high sequence similarity in S. cerevisiae database (Furukawa et al., 2000). 
The 99 amino acids (aa) long and β-grasp fold containing Urm1 protein shows 
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high identify to ThiS (20%) and MoaD (23%), particularly in the C-terminal region 
(Furukawa et al., 2000). ThiS, MoaD and the eukaryotic Urm1 are activated by 
adenylation at their C-terminal GG-motif by the E1-like enzymes ThiF, MoeB or 
Uba4 (MOCS3 in H. sapiens), respectively. It is believed that MoaB, ThiF and 
Uba4/MOCS3 most closely resemble the antecedent of the E1 superfamily (Taylor 
et al., 1998; Leimkühler et al., 2001; and Burroughs et al., 2009). Unlike most 
adenylated UBLs that form a thioester bond between the UBL and its E1, ThiS and 
MoaD are bound to ThiF and MoeB via an acyl disulphide, respectively (Fig. 2-3A) 
(Leimkühler et al., 2001; Xi et al., 2001; and Lehmann et al., 2006). In contrast to 
most UBLs, ThiS and MoaD do not conjugate to proteins, but serve as sulphur 
carriers in the thiamine and in the molybdenum-cofactor (MoCo) biosynthesis 
pathway, respectively (Pitterle et al., 1993; Taylor et al., 1998; Begley et al., 1999; 
Lake et al., 2001; Leimkühler et al., 2001; Wang et al., 2001). Remarkably, Urm1 
possesses a MoaD-related fold and is therefore structurally more similar to the 
prokaryotic sulphur carriers MoaD and ThiS than the eukaryotic UBLs (Xu et al., 
2006). Unlike most UBLs that are expressed as precursors, Urm1 is synthesized 
without any C-terminal extension preceding its functional GG-motif. It remains 
unclear how free Urm1 proteins are regulated. Notably, Urm1 is shown to dimerize 
in vitro resulting in the formation of a homodimer via its C-terminal ends that 
results in the internalization of the GG-motifs and potentially serves as a regulation 
for Urm1 conjugation activity (Yu & Zhou, 2008). Urm1 is highly conserved from S. 
cerevisiae to H. sapiens and contains a β-grasp fold (Furukawa et al., 2000; Xu et 
al., 2006).  
 
2.1.1  The Urm1 pathway 
A yeast-two hybrid (Y2H) screen using Urm1 as a bait led to the identification of 
the E1-like ubiquitin activating enzyme 4 (Uba4, MOCS3 in H. sapiens), whose N-
terminal region contains a MoeB-like domain showing high similarities to the E1 
domain of the eukaryotic Uba1, but also to the prokaryotic ThiF and MoeB 
(Furukawa et al., 2000; and Burroughs et al., 2009). Additionally, Uba4 contains a 
C-terminal rhodanese-like domain (RLD) that is present in many prokaryotic and in 
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all eukaryotic MoeB homologs (Hochstrasser, 2000; Mendel & Schwarz, 2002; 
Matthies et al., 2004; Krempinsky & Leimkühler, 2007; Schmitz et al., 2008; and 
Burroughs et al., 2009). Analogous to the activation of ubiquitin or ThiS/MoaD, 
Urm1 is first activated through the adenylation at its GG-motif by Uba4 (Fig. 2-3B). 
Adenylated Urm1 forms a covalent acyl-disulphide with Uba4 and is then released 
from Uba4 as a thiocarboxylated Urm1 intermediate (Fig. 2-3AB) (Pedrioli et al., 
2008; Schmitz et al., 2008; Schlieker et al., 2008; Nakai et al., 2008; Noma et al., 
2009; Hochstrasser, 2009; Leidel et al., 2009; Van der Veen et al., 2011 Wang et 
al., 2011). Interestingly, the two small archaeal modifiers (SAMP1 and SAMP2) 
function as protein modifiers and as sulphur carriers in tRNA thiolation and MoCo 
biosynthesis in a similar manner as the Urm1 system (Humbard et al., 2010; 
Miranda et al., 2011; and Anjum et al., 2015). Therefore, it is believed that Urm1 is 
a molecular fossil of the UBL family that is derived from its archaeal ancestors 
SAMP1/2 (Xu et al., 2006; Maupin-Furlow, 2013; and Anjum et al., 2015). 
Uba4 has two conserved cysteine residues that are vital for the thiocarboxylate 
formation of Urm1 and Urm1 function: C225 in the MoeB-like domain and C397 in 
the RLD (Furukawa et al., 2000; Matthies et al., 2005; Schmitz et al., 2008; Nakai 
et al., 2008; Leidel et al., 2009; Hochstrasser, 2009; Noma et al., 2009; Van der 
Veen et al., 2011; and Jüdes et al., 2016). To uphold Uba4 activity, Uba4 receives 
sulphur from the cysteine desulfurase Nfs1 and the RLD-containing sulfur 
transferase Tum1 (YOR251C) (Nakai et al, 2008; Leidel et al., 2009; Noma et al., 
2009; Huang et al., 2008; and Jüdes et al., 2016). To date no Urm1-specific E2, 
E3 or deurmylating enzyme has been identified. It has been speculated that Uba4 
might function as an E1- and E2-like hybrid (Hochstrasser, 2000), however this 
hypothesis has been challenged by the discovery of Urm1-Uba4 acyl-disulphide 
bond formation and of Urm1 thioester intermediates, since thioester bond 
formation are typically found in UBL-E2 conjugation (Pedrioli et al., 2008; Van der 
Veen et al., 2011; Wang et al., 2011). 
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Fig. 2-3. Analogies between the ubiquit in, Urm1 and ThiS pathways. 
(A) The thiocarboxylated ThiS functions as a sulphur carrier in the biosynthesis of thiamine. (B) Urm1 acts as 
a sulphur carrier and as a protein modifier. Analogous to ubiquitin and ThiS, Urm1 is activated at its carboxyl 
terminus by acyl-adenylation via the E1-like enzyme Uba4. The adenylated Urm1 covalently binds to Uba4 
forms a covalent Urm1-Uba4 binding. Through a series of enzymatic reactions, C-terminus of Urm1 is 
thiocarboxylated that is able to function as a sulphur donor in transfer RNA (tRNA) modification or as a protein 
modifier by an unknown mechanism. (C) Ubiquitin modifies proteins via an enzymatic cascade involving the 
enzymes E1, E2 and E3. Adopted from Pedrioli et al., 2008 and Wang et al., 2011. 
 
2.1.2  The role of Urm1 as sulphur carrier 
So far 144 different RNA modifications have been identified in all kingdoms of life 
of which an array of PTMs are found in transfer RNAs (tRNAs) that enhances 
translational fidelity, structural stability, codon recognition and decoding accuracy 
(El Yacoubi et al., 2012; Jackman & Alfonzo, 2013; Machnicka et al., 2013; 
Hopper, 2013; Nakai et al., 2017). One of tRNA modifications is found at wobble 
uridine U34 of tRNALys(UUU), tRNAGlu(UUC) and tRNAGln(UUG). Wobble U34 of tRNAs are 
commonly subjected to methoxycarbonylmethyl modification (mcm5U34) at the 5’ 
position by the Elongator complex and/or to the addition of a thiocarbonyl group 
(s2U34) at the uracil ring by the Urm1 pathway (Machnicka et al., 2013; Nakai et al., 
2017). Thiocarboxylated Urm1 together with the thiouridylase Ncs6 (“Needs Cla4 
to Survive 6” or cytosolic thiouridylase 1 (CTU1/ATPBD3) in H. sapiens) and Ncs2 
(CTU2 in H. sapiens) are likely to transfer the sulphur from the Urm1 C-terminus to 
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thiolate U34 and modify U34 to s2U34 (Fig. 2-3B) (Nakai et al., 2008; Dewez et al., 
2008; Leidel et al., 2009; Schlieker et al., 2008; and Noma et al., 2009). 
Modification of mcm5s2U34 helps codon-anticodon interaction necessary for 
efficient mRNA decoding and enhances translational fidelity (Jablonowski et al., 
2006; Johansson et al., 2008; Laxman et al., 2013; Rezgui et al., 2013; Tükenmez 
et al., 2015; and Nedialkova et al., 2015). Lack thereof in Elongator and Urm1 
pathway mutants result in a complete loss or strong reduction in mcm5s2U34 of 
tRNALys(UUU), tRNAGlu(UUC) and tRNAGln(UUG) and result in translational defects such 
as slower mRNA decoding, ribosomal stalling and subsequently protein 
aggregation (Nakai et al., 2004; Bjork et al., 2007;  Dewez et al., 2008; Leidel et 
al., 2008; Schlieker et al., 2008; Nakai et al., 2008; Noma et al., 2009; Nedialkova 
et al., 2015). Consequently protein abundance of ~260 proteins is decreased in S. 
cerevisiae due to inefficient translation of long mRNAs containing a high amount of 
codons for K, Q and E (Fig. 2-4) (Laxman et al., 2013; and Rezgui et al., 2013). 
While lack of mcm5U34 modification pathway has no effects on cell viability, the 
cells lacking components of the Urm1 pathway for s2U34 modification pathway 
have reduced or no viability under stress conditions such as oxidative stress, high 
temperatures, nutrient starvation and DNA damage (Furukawa et al., 2000; 
Goehring et al., 2003ab; Chen et al., 2009; Khoshnood et al., 2016; Damon et al., 
2015; and Schorpp, 2011). Lack of both mcm5U34 and of s2U34 causes lethality in 
S. cerevisiae and in C. elegans during embryogenesis at elevated temperatures 
(Bjork et al., 2007; Chen et al., 2009). Conversely, yeast lacking Urm1, Uba4 and 
Ncs6 are resistant to the Kluyveromyces lactis toxin γ-toxin that exclusively 
cleaves mcm5s2-modified tRNAs and causes G1 cell cycle arrest to WT cells 
(Fichtner et al., 2003; Lu et al., 2005; Huang et al., 2008; Jüdes et al., 2016). Urm1 
pathway mutants share certain phenotypes with target of rapamycin complex 1 
(TORC1) mutants such as rapamycin and caffeine sensitivity. Moreover, cells 
lacking Urm1 and Uba4 cause the mislocalization of the TORC1- and nutrient-
regulated transcription factors Gln3 and Gat1, which causes the misregulation of 
the TORC1-regulated target genes GAP1 and CIT2 and indicates the importance 
of the Urm1 pathway in nutrient sensing (Rubio-Texeira, 2007). Remarkably, 
sensitivity of rapamycin, caffeine and the oxidative stress inducing agent diamide 
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of Urm1-pathway mutants can be rescued by overexpression of unmodified 
tRNALys(UUU), tRNAGlu(UUC) and tRNAGln(UUG) indicating that these phenotypes 
together with the resistance towards to K. lactis γ-toxin and temperature sensitivity 
can be attributed to the absence of tRNA thiolation (Huang et al., 2008; Leidel et 
al., 2009; and Damon et al., 2015). 
 
2.1.3  Urm1, the protein modif ier 
In contrast to the well-studied role of Urm1 as a sulphur carrier in tRNA thiolation, 
the function of Urm1 as a protein modifier remains enigmatic. Until now, the 
mechanism of Urm1 protein-modification pathway and the function of urmylation 
are as yet unclear. Previous works have shown the presence of higher migrating 
Urm1 adducts under steady state conditions, which massively increases under 
oxidative stress in S. cerevisiae, and cells from D. melanogaster and H. sapiens 
(Furukawa et al., 2000; Goehring et al., 2003a; Van der Veen et al., 2011; and 
Khoshnood et al., 2016). However, Urm1 adducts were absent in absence of 
Uba4, the catalytically inactive uba4 variants (uba4 C225S/A, uba4 C397S/A, uba4 
C225, C397S), or yeast expressing urm1ΔG and urm1ΔGG truncations. This 
clearly indicates the existence of Urm1-modified substrates, whose Urm1 
modification requires an ATP-dependent activation of its C-terminal glycine by the 
enzymatic activity of Uba4. Since no Urm1-specific E2, E3 have been identified, it 
remains unclear how substrate recognition and specificity is achieved. In terms of 
protein modification by Urm1, Van der Veen et al. have demonstrated that Urm1 is 
covalently conjugated to Urm1 substrates via a covalent isopeptide bond, as Urm1 
conjugates are fairly resistant to reducing agents such as hydroxylamine 
Dithiothreitol (DTT) or hydroxylamine (NH2OH) (Van der Veen et al., 2011). In 
contrast to ubiquitination, urmylation requires a thiocarboxylated Urm1 
intermediate, but also an Urm1 thioester intermediate, which is commonly 
observed in canonical UBL modifiers, as well. Through a series of site-directed 
mutagenesis of the only known yeast Urm1-substrate Ahp1, it could be 
demonstrated that the Urm1 conjugation machinery recognizes and conjugates 
Urm1 to lysine (K) 32 of Ahp1 (Van der Veen et al., 2011). Whether all Urm1-
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substrates are conjugated at their acceptor lysine has yet to be determined. All 
known Urm1 substrates are modified by a single Urm1 moiety and no 
polyurmylation has been observed in all known Urm1 substrates (Goehring et al., 
2003a; Van der Veen et al., 2011; Khoshnood et al., 2016). Though no 
deurmylation enzymes have been identified in eukaryotes, Urm1 substrates seem 
to accumulate by the addition of the irreversible cysteine peptidase inhibitor N-
ethylmaleimide (NEM), which is commonly used as an inhibitor of deubiquitination 
and deSUMOylation, suggesting the possible existence of a deurmylation enzyme 
in eukaryotes (Goehring et al., 2003a; Van der Veen et al., 2011; and Schorpp, 
2011). Previous studies show a reduction of putative urmylated substrates in cells 
lacking Ncs2 and Ncs6 indicating a potential crosstalk between the Urm1 protein 
modification and sulphur carrier pathway (Goehring et al., 2003b). However, this 
finding could not be reproduced in later studies, which showed no influence of 
urmylation in Δncs2 or in human cells that have significantly reduced levels of 
ATPBD3/Ctu1 (Ncs6 in S. cerevisiae) (Schorpp, 2011; and Van der Veen et al., 
2011). Interestingly, components of the Urm1 pathway, such as Uba4/MOCS3, 
ATPBD3/Ctu1 and Ctu2 (Ncs2 in S. cerevisiae), among with the deubiquitinating 
enzyme USP15, the nucleocytoplasmic shuttling factor CAS (cellular apoptosis 
susceptibility protein), the peroxiredoxin Ahp1 that plays an essential role in 
cellular response to reactive oxygen species (ROS) in yeast and its ortholog Prx5 
in D. melanogaster are confirmed Urm1 substrates in vivo (Jeong et al., 1999; Lee 
et al., 1999; Van der Veen et al., 2011; and Khoshnood et al., 2016). Moreover, 
Van der Veen et al. identified a small set of potential Urm1 substrates via MS/MS, 
which are involved in various cellular pathways such as ubiquitination, tRNA 
modification, nuclear transport, RNA regulation and oxidative stress (Fig. 2-4) (Van 
der Veen et al., 2011). Urmylation is present under steady state conditions and is 
significantly elevated under oxidative stress (Furukawa et al., 2000; Goehring et 
al., 2003; and Van der Veen et al., 2011). Intriguingly, the Urm1 pathway 
distinctively responses to different oxidative stressors, as treatment with hydrogen 
peroxide (H2O2), diamide and tert-Butyl hydroperoxide (t-BOOH) induces the 
formation of specific sets of Urm1 adducts (Van der Veen et al., 2011; and 
Schorpp, 2011). Indeed, while Ahp1 is urmylated under steady state conditions 
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and under diamide treatment, Urm1 does not modify Ahp1 under t-BOOH 
treatment (Goehring et al., 2003a). 
Though the function of urmylation remains unclear, urmylation might play a 
detrimental role in oxidative stress tolerance, as oxidative stress has been shown 
to be a strong inducer of urmylation. In concordant to these findings, cells deficient 
of Ahp1, Urm1 and Uba4 show sensitivity towards various oxidative stress-
inducing drugs (Goehring et al., 2003a). Since Δahp1 cells do not share many 
phenotypes with Urm1-pathway mutants that result in pleiotropic phenotypes, 
Urm1 might function and modify additional proteins in other cellular process 
(Goehring et al., 2003ab). Indeed, urmylation plays an important role during 
embryogenesis and improves overall fitness of D. melanogaster (Khoshnood et al., 
2016). Urm1 expression and protein conjugation by Urm1 are highly elevated 
during early embryonic stages and during larval/pupal transition. Concordantly to 
the appearance of urmylation during embryogenesis, loss of Urm1 causes a high 
lethality rate among flies homozygous for urm1 either during embryogenesis or at 
late pupal stages, raising the question what proteins are modified by Urm1 
(Khoshnood et al., 2016). Around 20% of flies homozygous for urm1 reach 
adulthood, but display a significantly reduced lifespan compared to wild type and 
Urm1 revertant flies. Recent in vitro studies have shown that the archaeal 
Urm1/SAMP homologue of S. solfataricus modify proteins, which are in turn 
recognized by the 20S proteasome and by the ATPase proteasome-activating 
nucleotidase (PAN) (Anjum et al., 2015). Furthermore, in vitro experiments using 
N-terminal fusion of the archaeal Urm1 to GFP, mimicking Urm1-modified GFP 
species, showed the degradation of Urm1-GFP in presence of an active 20S 
proteasome suggesting that protein stability in S. solfataricus might be regulated 
by Urm1 and would therefore resemble the eukaryotic UPS. Unlike archaeal Urm1, 
Urm1-modified substrates in yeast and human were not subjected to protein 
degradation (Goehring et al., 2003; and Van der Veen et al., 2011). 
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Fig. 2-4. Dual function of Urm1 as a protein modif ier and a sulphur carr ier. 
 
2.2  Zinc Regulation in Yeast 
Zinc (Zn) is an indispensible trace element for all organisms and serves as 
cofactors in around 10% of all proteins in humans ranging from enzymes, 
receptors, and growth factors to transcription factors (Sugarman, 1983; Andreini et 
al., 2006; Broadley, 2007; Prasad, 2008; and Plum et al., 2010). Since 
metalloproteins and Zn-binding proteins are as ubiquitous as their role in biological 
processes such as oogenesis, embryogenesis, conception, immune response, and 
regulation of the central nervous system, a tight control of the intracellular zinc 
levels is therefore a requirement for cell survivability (Hambidge & Krebs, 2007; 
Prakash et al., 2015). Excess of intracellular zinc levels are toxic and can compete 
with other metal ions for the binding to transporter proteins, enzymes, and ligands. 
The regulation of zinc homeostasis is mediated by a multilayered regulatory 
mechanism including RNA expression, RNA stability, translation, degradation, zinc 
storage/conservation, zinc sensors such as metallothioneins and zinc trafficking 
via anterograde and retrograde zinc transporters (Hamer, 1986; Palmiter & 
Findley, 1995; Eide, 2003; Rutherford & Bird, 2004; Krezel & Maret, 2007; Fukada 
et al., 2011; and Bird, 2015). The expression of the zinc-regulatory proteins and 
zinc-transporters are controlled by metal-responsive transcription factors such as 
the metal-responsive transcription factor 1 (MTF-1) in insects, fish, reptiles and 
mammals (Brugnera et al., 1994; and Choi & Bird, 2014). While MTF-1 regulates 
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cupper, iron and zinc homeostasis in higher eukaryotes, S. cerevisiae possess 
three metal-responsive transcription factors each specialized in either regulating 
cupper, iron and zinc, respectively (Rutherford & Bird, 2004). The zinc 
homeostasis in yeast is controlled by the zinc-responsive activator protein 1 
(Zap1) (Zhao et al., 1997; Eide, 2009; and Wilson & Bird, 2016). Functional 
homologs of Zap1 have been identified in Cryptococcus gattii, Candida albicans, 
Candida dubliniensis and Aspergillus fumigatus, suggesting that the mechanism to 
regulate zinc homeostasis by Zap1 homologs might be a common mechanism 
among the fungal kingdom (Moreno et al., 2007; Kim et al., 2008; Schneider et al., 
2012; and Choi & Bird, 2014, Böttcher et al. 2015). 
In response to zinc deficiency, Zap1 activates genes, which either play roles in 
zinc homeostasis or survivability under zinc starvation (Fig. 2-5A) (De Nicola et al., 
2007; Wu et al., 2008; North et al., 2012; MacDiarmid et al., 2013). Under zinc-
limiting conditions Zap1 mediates the expression of FET4, which transports Zn2+, 
Cu2+ and Fe2+, and two high affinity Zn2+-specific ZIP-family transporters ZRT1 and 
ZRT2, whose homologs play a detrimental role in metal transport among all 
kingdoms (Fig. 2-5A) (Zhao & Eide, 1996ab; Gaither & Eide, 2001; Waters & Eide, 
2002; Kambe et al., 2006; and Choi & Bird, 2014). Zap1 activates target genes 
expression by binding to one or more zinc-responsive elements (ZREs) located 
within the target genes’ promoter region (Fig. 2-5B) (Zhao et al., 1998; and Wu et 
al., 2008). Moreover, Zap1 activates its own expression by binding to a single ZRE 
conserved among Zap1-like homologs (Fig. 2-5B) (Zhao et al., 1998; Moreno et 
al., 2007; Schneider et al., 2012; Böttcher et al., 2015). Under zinc-replete 
conditions, binding of Zn2+ to the transactivation domains (ADs) AD1 and AD2 of 
Zap1, which in turn inactivates the transcriptional activity of Zap1 under a yet 
unknown mechanism. (Fig. 2-5B) (Bird et al., 2000; Bird et al., 2003; Qiao et al., 
2006; Wang et al., 2006; and Frey & Eide, 2011). Even though the Zap1 zinc-
sensing ability is important to suppress Zap1 target genes, expression of the C-
terminal DNA-binding domain (DBD) of Zap1 enables binding to ZREs, which 
activates Zap1 target genes in a zinc-independent fashion, indicating an additional 
post-translational mechanism to control Zap1 expression (Frey et al., 2011; and  
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Fig. 2-5. Zap1 target genes and zinc-dependent autoregulatory mechanism of Zap1. 
(A) Functional role of known or putative Zap1 target genes in yeast. Upregulated genes are depicted in yellow 
and down-regulated genes are depicted in blue. Since ZRT2 is activated and repressed by Zap1 depending to 
the intracellular zinc concentration, ZRT2 is depicted in blue and yellow. Genes, depicted as grey circles, are 
not regulated by Zap1. MITO: mitochondria; PM: plasma membrane; ORF: open reading frame. Fig. 2-5A is 
adapted from Eide, 2009. (B) Zinc-dependent autoregulatory mechanism of Zap1. Under zinc-depleted 
conditions Zap1 is transcriptional active and activates ZAP1 transcription by binding to the zinc-responsive 
element (ZRE) of upstream ZAP1 ORF. Zn2+ binding to Zap1 transcriptionally inactivates Zap1 and hence 
represses ZAP1 transcription. 
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Wilson & Bird, 2016). Zap1 not only controls zinc-dependent homeostatic 
responses, but also targets genes in sulfate metabolism, cell wall function, 
phospholipid synthesis, protein turnover and ROS defense (Fig. 2-5A) (Eide, 
2009). Previous studies showed an increase of intracellular ROS levels under zinc-
limiting conditions, which, in turn, leads to DNA damage, and to protein and lipid 
oxidation (Powell, 2000; Ho, 2004; Wu et al., 2007). As a protective mechanism 
from zinc deficiency-induced oxidative stress, Zap1 activates the expression of the 
cytosolic peroxiredoxin Tsa1 and the cytosolic catalase Ctt1 under low zinc 
conditions (Wu et al., 2008). Intriguingly, deletion of URM1 and ZRT1 shows a 
significantly slower growth indicating a possible connection between the Urm1 
pathway and the Zap1 signaling pathway (Costanzo et al., 2010). 
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Aim of this work 
The dual role of Urm1 as a sulphur carrier and protein modifier combines 
seemingly unrelated features of the prokaryotic sulphur carrier system and the 
eukaryotic protein modification system, suggesting that Urm1 may be an 
evolutionary fossil of the UBL family. While the sulphur carrier function of Urm1 in 
tRNA thiolation has been revealed, the protein modifier function of Urm1 remains 
largely unclear. Aside from this, only few proteins have been identified as Urm1-
substrates. Although numerous Urm1 adducts are present under regular growth 
conditions and upon oxidative stress, the peroxiredoxin Ahp1 is the only known 
Urm1 substrate in yeast, raising the question whether more proteins are modified 
by Urm1. Since Urm1 targets a specific lysine residue of Ahp1, it is conceivable 
that Urm1 may conjugate more proteins in a similar fashion. Despite extensive 
research on Ahp1 and its function in ROS defense, the role of Ahp1 urmylation 
continues to be ambiguous. 
In this study, we aimed to elucidate the function of protein urmylation in vivo. To 
address this question, an unbiased tandem mass spectrometry (MS/MS) screen 
was conducted to identify novel lysine-directed Urm1 substrates. Candidates were 
verified by biochemical methods and thus served as model substrates in 
investigating the mechanistic and cellular consequences of urmylation. 
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3  Results 
3.1  Identif ication of novel Urm1-substrates 
Although the role of Urm1 as a sulfur carrier in tRNA modification is adequately 
described (Leidel et al., 2009, Rezgui et al., 2013, Laxman et al., 2013 and 
Nedialkova & Leidel, 2015) the function of Urm1 as a protein modifier remains 
unknown. To date only few urmylated substrates are identified, such as MOCS3 
(Uba4 in S. cerevisiae), ATPBD3, CTU2, USP15 and CAS in mammalian cells 
(Van der Veen et al., 2011), Uba4 and the thiol-specific peroxiredoxin Ahp1 in S. 
cerevisiae, respectively (Goehring et al., 2003ab, Schorpp, 2011). To date, no 
functional relevance of Urm1 modification has been assigned to any of the above-
mentioned Urm1 substrates.  
Urm1 conjugation to Ahp1 is covalent and requires the ε-amino group of acceptor 
lysine (K) residues of Ahp1 and the enzymatic activity of the E1-like enzyme Uba4 
(Van der Veen et al., 2011 and Schorpp, 2011). In this work a SILAC-based mass 
spectrometry approach was performed to screen for novel Urm1-substrates and to 
identify urmylation sites, which would allow a greater understanding of the 
functional consequences of urmylation (Ong et al., 2002, Mann, 2006; Andersen et 
al., 2009, Matic et al. 2010; and Psakhye & Jentsch, 2012). Tryptic-digestion of 
Urm1 conjugated proteins produces branched peptides in which the C-terminal 
fragment of Urm1 is attached to a lysine residue within the target peptide. Thus, a 
proteomic search for specific peptides derived from trypsin-digested Urm1-
substrate branched conjugates (i.e. Urm1 branched peptides) could allow mapping 
of so far unknown urmylation sites. Detection of Urm1 branched peptides is 
challenging using wild type (WT) Urm1, as tryptic digestion of WT Urm1 results in 
very long Urm1 branched peptides (K/R…KDYILEDGDIISFTSTLHGG-ε-K…K/R). These 
masses would generate complex LC-MS/MS spectra making the identification of 
such Urm1 branched peptides demanding (Matic et al., 2008; and Matic & Hay, 
2012). To increase the probability of identifying Urm1-substrate branched 
peptides, a modified yeast strain expressing an Urm1 variant was constructed that 
would generate shorter Urm1 branched peptides (Δurm1 HisHAurm1-L96R) (Fig. 3-
1A). Tryptic digestion of urm1-L96R with its covalently attached target protein 
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would yield in K/R…HGG-ε-K…K/R (HGG-ε-K) Urm1 branched peptides and ought 
to improve the detection of urmylation sites via mass spectrometry. To determine 
whether the HisHAurm1-L96R variant can function as a WT version of Urm1, zeocin 
sensitivity of different Δurm1 mutant strains (as described in Schorpp, 2011) was 
tested (Fig. 3-1B). ∆urm1 cells show high sensitivity at already low concentrations 
of zeocin, whereas Δurm1 cells expressing HisHAurm1-L96R could rescue the 
sensitivity of the Δurm1 strain entirely. Δurm1 HisHAurm1-L96R cells with an 
additional deletion of the E1 enzyme Uba4 were once again sensitive to zeocin. 
Moreover the conjugation of HisHAurm1-L96R to protein substrates was also 
investigated (Fig. 3-1C). As previously shown, N-ethylmaleimide (NEM) enhances 
Urm1-conjugation (Van der Veen et al., 2011 and Schorpp, 2011). Both HisHAUrm1 
and HisHAurm1-L96R showed a comparable urmylation pattern in cells treated with 
and without NEM. Thus, the HisHAurm1-L96R strain appears to be suitable to  
 
 
Figure 3-1. Construction of a modif ied yeast strain to identify lysine-directed Urm1 
substrates. (A) Schematic of the Urm1 expression constructs. Tryptic digestion of HisHAurm1-L96R gives rise 
to a short HGG-ε-K branched peptide. HisHAurm1-L96R was integrated at the LEU2 locus of Δurm1 cells 
(HisHAurm1-L96R). The arrow indicates the tryptic cleavage site. (B) HisHAurm1-L96R is able to rescue the 
zeocin-induced sensitivity of Δurm1 cells, indicating that this variant does not interfere with Urm1 functions in 
yeast cells. Cells were plated in 5-fold dilutions on YPD with or without zeocin and incubated for 3 days at 
30°C. HisHAurm1-L96R was integrated at the LEU2 locus of Δurm1 (HisHAurm1-L96R) and of Δurm1 Δuba4 
(HisHAurm1-L96R Δuba4). (C) Urm1 conjugation pattern in yeast strains expressing HisHAUrm1 and HisHAurm1-
L96R. Cells were grown at 30°C either with (+) or without (-) 1h of 10 mM NEM incubation. Samples were 
collected and subjected to immunoblotting using anti-HA antibodies to detect HisHAUrm1. Dpm1 levels serve as 
a loading control. 
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screen for novel Urm1-substrates (Fig. 3-2A). To this end, the HisHAurm1-L96R 
strain was used to first enrich Urm1 and Urm1-conjugates in a denaturing Ni-NTA 
pull-down followed by a SILAC-based LC-MS/MS method that allows the 
quantitative detection of changes in protein abundance among differentially treated 
samples. Subsequently, isolated Urm1-conjugates from untreated and NEM-
treated cells were analyzed using the LC-MS/MS method. The LC-MS/MS screen 
identified 547 potential Urm1 substrates in total, of which a small subset of 21 
Urm1-substrates were significantly enriched upon NEM-treatment (H/L ratio of >1 
and a p-value of <0.05, Fig. 3-2B). Among these candidates, proteins are found 
associated with various cellular processes such as glycolysis (Pyk1, Tdh2 and 
Tdh3), sterol metabolism (Nsg2), protein biosynthesis (Ses1), RAS-cAMP pathway  
 
Figure 3-2. Purif ication and identif ication of urmylated substrates. 
 (A) Overview of the experimental workflow for the purification and identification of Urm1-modified substrates 
with HGG-ε-K linkages using the mutant variant HisHAurm1-L96R. (B) Scatter plot of normalized SILAC H/L 
ratios (NEM-treated versus untreated) for 547 quantified proteins were plotted against the sum of the 
respective peptide intensities. Proteins are color-coded according to their respective p-values, with red circles 
having values <0.001, orange circles between 0.001 and 0.01, yellow circles between 0.01 and 0.05 and blue 
circles >0.05. (C) A single Urm1-conjugation site of Zap1 was identified at K871. Following Ni-NTA pull-down, 
HisHAUrm1-conjugates were digested with trypsin. Branched peptides with HGG-ε-K linkages were detected 
and identified by LC-MS/MS and MaxQuant, respectively. 
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(Ira2), ubiquitin pathway (Ubp11), and zinc metabolism (Zap1) (Tab. 3-1). 
Together with the previously described Urm1-substrate Ahp1, proteins of the Urm1 
pathway (Nfs1 and Uba4) were identified among the targets. Unlike previous 
studies, Ahp1 urmylation was not increased upon NEM treatment (Van der Veen et 
al., 2011; and Schorpp, 2011). 
Common quantification errors in SILAC experiments are due to an incomplete 
incorporation of isotopic amino acids and arginine-to-proline conversions that lead 
to reduced ion intensities of the ‘heavy’ labeled peptides that results in a reduced 
H/L ratio (Ong et al., 2003; and Park et al., 2012). Previous studies have shown 
that a reciprocal label-swap replication experiment would reduce the preceding 
technical errors (Park et al., 2012). For this reason, a label-swap replication 
experiment was performed in parallel. The LC-MS/MS analysis of the label-swap 
experiment revealed that 17 proteins of the 21 identified proteins had a negative 
H/L ratio, strongly indicating that these proteins were urmylated upon NEM 
treatment (Tab. 3-1). In order to ensure reproducibility and comparability of the 
generated data, we repeated the experiments twice using HisStrepurm1-L96R in 
label-free LC-MS/MS analysis. Most proteins that were identified from the previous 
SILAC experiment were identified once or twice in the above-mentioned replication 
experiments (Tab. 3-1). Furthermore, to demonstrate that the urm1-L96R variant 
modifies the same set of proteins as WT Urm1 upon NEM-treatment, a yeast 
strain expressing HisHAUrm1 and HisStrepUrm1 was generated and used in following 
denaturing purification experiments: (1) SILAC with HisHAUrm1 without NEM vs. 
HisHAUrm1 with NEM; (2) SILAC with HisHAUrm1 Δuba4 with NEM vs. HisHAUrm1 with 
NEM and (3) two label-free LC-MS/MS experiments with HisStrepUrm1 in presence 
of NEM (Tab. 3-1). In summary, all of the highly accumulated substrates that were 
previously found in HisStrepurm1-L96R could be identified in the experiments 
conducted with WT HisStrepUrm1. In addition the urm1-L96R variant allows 
prediction of protein urmylation sites by identifying HGG-ε-K branched peptides. In 
total, 59 proteins with their respective HGG-ε-K branched peptides were detected 
in the entirety of all purification experiments using the urm1-L96R variant. In one of 
the label-free experiment, we were able to identify three tryptic branched peptides 
of Urm1-Ahp1 at K41, K107 and K32, which was previously identified as the 
RESULTS 
 22 
urmylation site of Ahp1 (data not shown, Van der Veen et al., 2011). Out of the 21 
highly accumulated substrates, we were able to find HGG-ε-K branched peptides, 
which could be assigned to 5 proteins (Tab. 3-1). Importantly, the zinc-responsive 
activator protein (Zap1) was identified as Urm1-substrate in several repetition 
experiments using HisHAurm1-L96R variant and wild type Urm1 with NEM-treated 
cells. Moreover, an Urm1-Zap1 branched peptide at K871 was identified, signifying 
a likely acceptor lysine residue for Zap1 urmylation (Fig. 3-2C, Tab. 3-1). 
Additionally, we could confirm Zap1 with a negative H/L ratio in a reciprocal label-
swap replication experiment, confirming NEM-induction (Fig. 3-2C). 
 
 
Table 3-1. List of HisHAurm1-L96R  modif ied proteins signif icantly enriched in NEM-treated 
cells.  
Proteins are color-marked according to their respective p-values, with red having values <0.001, orange 
between 0.001 and 0.01, and yellow between 0.01 and 0.05. Experiments in which the respective proteins are 
detected using WT Urm1: (1) HisHAUrm1 (-NEM; ‘light’ medium) vs. HisHAUrm1 (+NEM, ‘heavy’ medium); (2) 
HisHAUrm1 Δuba4 (+NEM; ‘light’ medium) vs. HisHAUrm1 (+NEM; ‘heavy’ medium); (3) label-free experiments 
LC-MS/MS analysis of HisStrepUrm1 and HisHAurm1-L96R: (1) label-swap replication experiment (+NEM; ‘light’ 
medium) vs. (-NEM, ‘heavy’ medium); (2) label-free experiment LC-MS/MS analysis of HisHAurm1-L96R. 
*Urm1-substrate branched peptide detected in replicates using HisStrepurm1-L96R. 
 
Systematic name Standard name Protein description Urm1 urm1-L96R HGG-K Site Positions
YNL156C NSG2 sterol biosynthesis yes yes
YOL081W IRA2 GTPase-activator protein for Ras-like GTPase yes no
YKR098C UBP11 Ubiquitin carboxyl-terminal hydrolase yes yes
YJR009C TDH2 Glyceraldehyde 3-phosphate dehydrogenase yes yes 331*
YGR192C TDH3 Glyceraldehyde 3-phosphate dehydrogenase yes yes 331*
YDR422C SIP1 5'-AMP-activated protein kinase yes yes
YIL008W URM1 yes yes
YAL038W PYK1 Pyruvate kinase yes yes 135;233;236*
YNR021W YNR021W Protein of unknown function yes yes
YOR070C GYP1 Cis-golgi GTPase-activating protein (GAP) for yeast Rabs yes yes
YBR171W SEC66 Preprotein translocase subunit Sec66 yes yes
YKR075C YKR075C Unknown function yes yes
YNL169C PSD1 Phosphatidylserine decarboxylase yes no
YPL224C MMT2 Cation efflux family yes yes
YDR233C RTN1 Reticulon yes yes
YMR183C SSO2 SNARE domain;Syntaxin yes yes
YDR023W SES1 Cytosolic seryl-tRNA synthetase yes no
YDL025C RTK1 Putative protein kinase yes yes 177*
YML048W GSF2 Endoplasmic reticulum (ER) localized integral membrane protein yes yes
YJL056C ZAP1 Zinc-responsive activator protein 1 yes yes 871
YHL023C RMD11 Subunit of the Iml1p/SEACIT complex yes yes
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3.2  Zap1 – a novel Urm1-substrate 
3.2.1  Urm1 modif ies Zap1 
Zap1 is a zinc-regulated transcription factor (Zhao & Eide, 1997), which is not only 
the master regulator of zinc uptake, homeostasis (Zhao & Eide, 1996ab), 
conservation (Lyons et al. 2000), storage (MacDiarmid et al., 2000) and 
detoxification (Miyabe et al., 2000 and MacDiarmid et al., 2003), but is involved in 
various adaptive processes such as sulfate metabolism (De Nicola et al. 2007 and 
Wu et al., 2008), cell wall function, phospholipid synthesis, protein turnover and 
ROS defense (Wu et al., 2007 and Wu et al., 2008). Zap1 also regulates its own 
expression via a positive auto-regulatory mechanism (Zhao & Eide, 1997). This 
transcriptional auto-regulation is controlled through the binding of Zap1 to a short 
DNA sequence called zinc-responsive element (ZRE), which is located upstream 
at the ZAP1 promoter. Zap1 binding to ZRE occurs under zinc-deficient conditions 
and thus potentiates the transcriptional activity of Zap1. Zap1 acts as a zinc 
sensor by directly binding to Zn2+ ions.  
To confirm Zap1 as bona fide Urm1-substrate, HisStrepUrm1 was first purified 
using a denaturing tandem affinity purification (TAP) method (adapted from 
Tagwerker et al., 2006; and Maine et al., 2010) and immunoblotted against 
urmylated Zap1 using anti-HA antibodies (Fig. 3-3). A slower-migrating Zap1HA-
species was detected in cells expressing Zap1HA and HisStrepUrm1, corresponding 
to an Urm1-modified Zap1 variant. 
 
 
Figure 3-3. Zap1 is a novel Urm1 substrate. 
Detection of urmylated Zap1HA using tandem affinity purification of HisStrepUrm1. Zap1 urmylation was verified 
by a denaturing Ni-NTA pull-down of HisStrepUrm1 followed by denaturing Strep-tag purification (TAP). Prior to 
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TAP, cells were treated with 10 mM NEM for 1h at 30°C. Samples were subjected to immunoblotting using 
anti-Urm1 antibodies to detect HisStrepUrm1 and anti-HA antibodies to detect Zap1HA. Dpm1 levels serve as a 
loading control. The C-terminal HA-tag was integrated at the endogenous ZAP1 locus. HisStrepUrm1 was 
integrated at the LEU2 locus of Δurm1.  
 
3.2.2  Urm1 influences the transcriptional activity of 
Zap1  
Initial experiments have shown that Zap1 levels were significantly decreased in 
Δuba4 and cells expressing zap1-K871R (KR) that no longer has the predicted 
lysine residue for Zap1 urmylation (data not shown). We therefore wondered if the 
decrease of Zap1 levels was dependent on intracellular zinc concentrations. To 
this end, we constructed yeast strains that contain a C-terminally HA-tagged Zap1 
variant expressed from its endogenous locus. WT, Δurm1 cells expressing Zap1HA 
or zap1-K871RHA were grown in either zinc-limiting (-Zn) or zinc-replete (+Zn) 
conditions. As expected, addition of zinc drastically reduces the expression of 
Zap1HA, but Zap1HA levels were decreased in Δurm1, KR and Δurm1 KR 
independent of zinc abundance when compared with WT (Fig 3-4A). We therefore 
checked whether the ZAP1 expression was affected by lack of urmylation. To this 
end, we quantified mRNA levels via the real time RT-qPCR method. Absolute 
amounts of ZAP1 mRNA were quantified in WT, Δurm1 cells expressing WT Zap1 
or WT cells expressing zap1-K871RHA that were grown in zinc-replete (+Zn) and 
zinc-deficient conditions (-Zn). While expression of ZAP1 mRNA levels were 
downregulated under zinc-replete conditions, ZAP1 expression was upregulated 
under zinc-limiting conditions (Fig. 3-4B). Compared to WT, ZAP1 expression was 
reduced by approximately two-fold in Δurm1, zap1-K871RHA and Δurm1 zap1-
K871RHA under zinc-limiting conditions. Consequently, we investigated, if the 
expression of the Zap1 downstream target Zrt1 is affected by the absence of 
urmylation. Indeed, ZRT1 expression was slightly downregulated in Δurm1, in 
zap1-K871RHA and Δurm1 zap1-K871RHA (Fig. 3-4C). 
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Figure 3-4. Loss of Zap1 urmylation results in decreased Zap1 level and reduced 
transcript ional activity of Zap1. 
(A) Zap1 levels are reduced in absence of Zap1 urmylation. WT, Δurm1 expressing endogenous Zap1HA or 
zap1-K871RHA were grown exponentially in either LZM containing 1 mM (+) or 3 μM (-) ZnCl2 at 30°C. 
Samples were subjected to immunoblotting using anti-HA antibodies to detect Zap1HA. Dpm1 levels serve as a 
loading control. (B) Real-time RT-qPCR analysis of ZAP1 gene expression of cells WT, Δurm1, zap1 K871R 
and combinations grown to log phase in zinc-abundant 1mM ZnCl2 LZM (+Zn) and switched to zinc limiting 
conditions in 3 μM ZnCl2 LZM (-Zn) at 30°C for 4.5h. Fold change was calculated relative to -Zn/+Zn ratio. 
Transcripts were normalized to the housekeeping gene ACT1. Normalized ZAP1 mRNA of cells grown in +Zn 
were set to 1. Values are mean for n=2. (C) Quantitative reverse transcription PCR (RT-qPCR) of ZRT1 
mRNA under zinc-limiting conditions. WT, Δurm1 cells, cells expressing zap1 K871R or combinations were 
grown to log phase in LZM containing either 1000 μM or 3 μM ZnCl2 at 30°C for 4.5h. mRNA was extracted 
from cells and cDNA was generated by using the RT-PCR method. Shown are the relative ZRT1 mRNA levels 
normalized to the housekeeping gene ACT1. Normalized ZRT1 mRNA signal were set to 1. Values are mean 
for n=2.  
 
3.2.3  Urmylation in response to zinc-deficiency 
Prior studies have shown that zinc deficiency increases intracellular levels of 
reactive oxygen species (ROS) (Powell et al., 2000; and Ho, 2004), which in turn 
leads to DNA damage and to protein and lipid peroxidation. Since both Urm1 and 
Zap1 play a vital role in ROS defense (Goehring et al., 2003a; Khoshnood et al., 
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2016; Wu et al., 2007, 2009; and MacDiarmid et al., 2013), we wondered if 
urmylation is changed under zinc-limiting condition. Therefore, Δurm1 cells 
expressing HisStrepUrm1 under the constitutive ADH1 promoter were grown with 
NEM, the oxidizing reagent tert-Butyl hydroperoxide (t-BOOH) or with a limiting 
zinc medium (LZM) (Fig. 3-5). Even though Zap1 urmylation does not seem to be 
increased by zinc-deficiency (data not shown), more substrates are urmylated 
upon zinc-deficient conditions. While cells grown in YPD show few urmylated 
substrates, cells grown in LZM showed increased amounts of Urm1-conjugates 
indicating that zinc deficiency might be an additional trigger for urmylation. NEM 
and t-BOOH served as controls as it is known that these substances strongly 
induce urmylation. 
 
Figure 3-5. Effects of oxidative stress and low zinc condit ions on Urm1 conjugation. 
Cells expressing HisStrepUrm1 under the control of the constitutive ADH1 promoter were grown in YPD and 
switched to 10 mM NEM, 1.5 mM t-BOOH or zinc-limiting LZM containing 3 μM ZnCl2. Samples were then 
taken after the indicated time points and subjected to immunoblotting using Urm1-specific antibodies to detect 
Urm1. Asterisk indicates cross-reactive bands. 
 
3.2.4  Role of Urm1 in zinc-deficiency 
Since several urmylated substrates accumulate under zinc-limiting conditions, we 
next investigated, if cells lacking Urm1 or Uba4 were sensitive under zinc 
deficiency. Therefore, cells were grown on either zinc-replete (+Zn) or zinc-limiting 
(-Zn) medium (Fig. 3-6A). Cells lacking either Urm1 or Uba4 show a strong 
sensitivity towards zinc-limiting conditions. zap1-K871RHA however showed no 
sensitivity towards zinc-limiting conditions. As previously shown, Zap1 levels are 
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lower in absence of Urm1 and in cells expressing zap1-K871R under zinc-replete 
and –limiting conditions potentially caused by a decrease in transcriptional activity 
of Zap1 and/or due to a destabilization of Zap1 caused by lack of Zap1 urmylation 
(Fig. 3-4A). Hence, we wondered whether constitutively urmylated Zap1 in Δurm1, 
Δuba4 and zap1-K871R improves the stability Zap1, which in turn reverts the 
sensitivity of cells lacking Urm1, Uba4 and cells expressing zap1-K871R. To mimic 
a constitutively urmylated Zap1 species, the fusion protein zap1-urm1ΔGGHisHA 
was constructed and integrated into the endogenous ZAP1 locus (or ZAP1-K871R 
locus) in WT, Δurm1 and Δuba4 cells. To assess the expression of zap1-
urm1ΔGGHisHA in WT, Δurm1, Δuba4 and zap1-K871R, protein levels of zap1-
urm1ΔGGHisHA are evaluated (Fig. 3-6B). In contrast to the lowered levels of 
Zap1HA in Δurm1 and in zap1-K871RHA expressed in WT (Fig. 3-4A), zap1-
urm1ΔGGHisHA levels are comparable between WT, zap1-K871R and Δurm1 cells. 
However, zap1-urm1ΔGGHisHA levels are lower in Δuba4 cells compared to WT. 
Cell-growth of the above-mentioned strains expressing zap1-urm1ΔGGHisHA are 
subsequently tested on zinc-replete and -limiting conditions (Fig. 3-6A). In contrast 
to the zinc sensitivity of Δurm1 and Δuba4, Δurm1 and Δuba4 expressing of zap1-
urm1ΔGGHisHA show no or slight sensitivity to zinc-limiting conditions, respectively. 
This finding suggests that Urm1-modification of Zap1 is vital for cell survival under 
zinc deficiency. Previous studies indicate that Zap1 plays a role in oxidative stress 
tolerance by activating the thioredoxin peroxidase Tsa1 and the cytosolic catalase 
Ctt1 (Wu et al., 2007, 2009). To test whether Zap1 and Zap1 urmylation protect 
cells under oxidative stress, we spotted cells in serial dilution on YPD and on YPD 
containing t-BOOH (Fig 3-6C). Cells lacking Zap1 show an equivalent sensitivity to 
t-BOOH seen in Δurm1, Δuba4 and Δzap1 Δurm1. Yet, zap1-K871RHA showed no 
sensitivity to t-BOOH. Expression of zap1-urm1ΔGGHisHA could partially rescue the 
sensitivity of Δurm1, but not in cells lacking Uba4, suggesting that Urm1-
modification of Zap1 plays a vital role in the cell survivability under zinc-limiting 
conditions, but to a lesser extent under oxidative stress. Though the expression of 
zap1-urm1ΔGGHisHA in Δurm1 fully or partially reverts the sensitivity to zinc 
deficiency and oxidative stress, respectively, cells lacking Uba4 expressing zap1-
urm1ΔGGHisHA are partially sensitive to zinc-limiting conditions and strongly  
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Figure 3-6. Epistat ic analysis of Δurm1 ,  Δuba4 ,  Δzap1 ,  zap1 K871R and zap1-urm1ΔGGHisHA 
under zinc-l imit ing and oxidative stress-induced condit ions. 
(A) WT strain or strains lacking Urm1, Uba4, Zap1 or combinations expressing either Zap1 or zap1-
urm1ΔGGHisHA under the endogenous ZAP1 promoter were grown over night. To create zap1-urm1ΔGGHisHA, 
urm1ΔGGHisHA::LEU2 was integrated to the C-terminal ZAP1 locus. Five-fold serial dilutions of cells (adjusted 
to OD600 = 0.5) were spotted on LZM plates either containing 1 mM (+Zn) or 3 μM ZnCl2 (-Zn). Plates were 
incubated at 30°C for 3 days. (B) WT, Δurm1 and Δuba4 cells expressing either zap1-urm1ΔGGHisHA or zap1 
K871R-urm1ΔGGHisHA under the endogenous ZAP1 promoter were grown in LZM with 3 μM ZnCl2 (- Zn) at 
30°C. Samples were subjected to immunoblotting using anti-HA antibodies to detect zap1-urm1ΔGGHisHA or 
zap1 K871R-urm1ΔGGHisHA, respectively. (C) WT strain or strains lacking Urm1, Uba4, Zap1 or combinations 
expressing either Zap1 or zap1-urm1ΔGGHisHA under the endogenous ZAP1 promoter were grown over night. 
Five-fold serial dilutions of cells (adjusted to OD600 = 0.5) were spotted on YPD plates and on YPD plates 
containing 1 mM t-BOOH. Plates were incubated at 30°C for 3 days. 
 
sensitive to oxidative stress (Fig. 3-6AC). This sensitivity might stem from the 
significantly lower zap1-urm1ΔGGHisHA levels Δuba4 compared with the zap1-
urm1ΔGGHisHA levels in WT and Δurm1, and zap1-K871R-urm1ΔGGHisHA 
expressed in WT (Fig. 3-6B). 
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3.2.5  Prerequisites for Zap1 urmylation 
Due to the multi-layered Zap1 regulation through its own transcriptional activation 
via a positive auto-regulatory mechanism and as a zinc sensor, we examined the 
zinc-dependency of Zap1 urmylation. In zinc-replete conditions, zinc ions are able 
to bind residues embedded in the transactivation domains AD1 and AD2 (Fig. 3-
7A, red and orange box), which in terms inhibit the transcriptional activity of Zap1. 
Prior studies have shown that the Zap1 truncation zap1552-880 (zap1-AD2) is 
transcriptionally impaired, as it lacks AD1 (Bird et al., 2000ab, Fig. 3-7A). Similarly, 
the N-terminal truncation zap1Δ17-700 (zap1-DBD), that lacks both transactivation 
domains AD1 and AD2, shows no transcriptionally activity. Importantly, however, 
both truncations are able to bind to ZREs (Frey & Eide, 2011). To investigate 
whether the transcriptional activation domains are necessary for Zap1 urmylation, 
we constructed the zap1 truncations zap1-AD2HA and zap1-DBDHA using the 
constitutive CYC1 promoter to bypass the transcriptional positive feedback loop 
(Fig. 3-7A). To see whether zap1-AD2HA or zap1-DBDHA were urmylated the 
denaturing Ni-NTA pull-down method was used to purify HisStrepUrm1 and 
potentially urmylated zap1-AD2HA or zap1-DBDHA (Fig. 3-7B). Indeed, a slower 
migrating urmylated species of zap1-AD2HA and zap1-DBDHA could be detected 
indicating that the activation domains AD1 and AD2 are not required for Zap1 
urmylation. Since both Zap1 truncations are shown to bind to ZREs via the DNA-
binding domain (DBD), we examined whether Urm1-modification of Zap1 depends 
on the presence of the DBD domain. Therefore, a Green fluorescent protein 
(GFP)-tagged C-terminal Zap1 variant under the control of CYC1 promoter, 
containing the last 64 aa of Zap1 C-terminus, was integrated in WT and in Δuba4 
expressing HisStrepUrm1 (zap1-C, Fig. 3-7C). Compared to endogenous expressed  
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 Figure 3-7. Urm1 modif ies Zap1 at K871. 
(A) Schematic diagram of full-length Zap1 and truncated Zap1-fragments lacking AD1 (zap1-AD2) or both 
activation domains (zap1-DBD). Both truncations are able to bind ZREs. However, zap1-AD2 displays low 
transcription activity, while zap1-DBD shows no transcriptional activity. Both constructs are expressed under 
the CYC1 promoter, possess a C-terminal HA-tag and are integrated into the LEU2 locus. Transactivation 
domains AD1 and AD2 are shown as red and orange boxes, respectively, while the DNA-binding domain 
DBD, consisting of five zinc fingers, is marked in blue boxes. (B) Cells expressing zap1-AD2 or zap1-DBD 
with His-Strep-tagged or untagged Urm1 under the control of the constitutive ADH1 promoter were treated 
with 10 mM NEM for 1h at 30°C. HisStrepUrm1 was purified using a denaturing Ni-NTA pull-down to detect 
urmylated truncated Zap1-fragments. Samples were subjected to immunoblotting using Urm1-specific 
antibodies to detect HisStrepUrm1 and anti-HA antibodies to detect HA-tagged zap1-variants. Dpm1 levels serve 
as a loading control. (C) The 64 aa long C-terminal fragment zap1-C, which lacks both activation domains 
and the DNA-binding domain, was expressed under the CYC1 promoter. zap1-C was N-terminally GFP-
tagged and integrated into the LEU2 locus. Urmylated zap1-C species was detected by Ni-NTA pull-down of 
either HisStrep-tagged or untagged Urm1. Prior to Ni-NTA pull-down, cells were treated with 10 mM NEM for 
1h at 30°C. Samples were subjected to immunoblotting using Urm1-specific antibodies to detect HisStrepUrm1 
and anti-GFP antibodies to detect zap1-C. Dpm1 levels serve as a loading control. (D) Urm1 modifies zap1-C 
at K871. A lysine to arginine mutation of the neighboring lysine residue zap1-C-K877R or a cysteine to serine 
substitution of zap1-C-C872S did not abolish urmylation. However, zap1-C-K871R was no longer urmylated. 
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full-length Zap1, GFPzap1-C fragment protein levels are higher and affected from 
the presence or absence of Uba4. Thus, we were able to use these novel strains 
and test the influence of Uba4 on urmylation of Zap1. Using the denaturing Ni-NTA 
pull-down method to purify HisStrepUrm1, a slower migrating urmylated GFPzap1-C 
species was detected in WT cells expressing GFPzap1-C and HisStrepUrm1, but not in 
cells lacking Uba4, indicating that Zap1 urmylation is Uba4-dependent (Fig. 3-7C). 
According to previous experiments we generated GFPzap1-C variants, which 
possess lysine to arginine substitutions at either K871, the neighboring K877 or a 
cysteine to serine substitution at C872 (Fig. 3-7D). GFPzap1-C and all GFPzap1-C 
variants, but GFPzap1-C K871R, were urmylated. This result implies that the Urm1-
conjugation machinery is able to specifically recognize and urmylate the predicted 
acceptor lysine residue K871 in the zap1-C fragment and possibly urmylate full-
length Zap1 at K871. 
 
3.2.6  Zap1 urmylation occurs in the cytoplasm 
Next we investigated whether Zap1 urmylation occurs in specific compartments 
(e.g. nucleus or cytoplasm) or in the entire cell. Previous microscopic and 
subcellular fractionation assays show that the localization of overexpressed Zap1 
under the inducible GAL promoter is nuclear (Bird et al., 2000, Frey et al., 2011). 
However, overexpression of Zap1 results in zinc-independent transcriptional 
activation of target genes such as ZRT1 due to the zinc-independent and 
constitutive binding of Zap1 to the chromatin via the ZREs (Frey et al., 2011). To 
examine the localization of endogenous Zap1, we integrated a GFP-tag at the C-
terminus of the ZAP1 locus (Fig. 3-8A). Zap1GFP was predominantly localized at 
the cytoplasm as speckled dots and only a fraction of Zap1GFP was found in the 
nucleus. As previously demonstrated, zap1-AD2 also localized in the cytoplasm as 
speckled dots and to the nucleus (Bird et al., 2000). We therefore speculated if a 
nuclear localization signal (NLS) is localized within the C-terminus of Zap1. Using 
NLS-Mapper (http://nls-mapper.iab.keio.ac.jp/, Kosugi et al., 2009), we were able 
to identify a putative bipartite NLS at 847-876 aa within Zap1. Consequently, we  
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Figure 3-8. Zap1 urmylation occurs in the cytoplasm. 
(A) Live cell fluorescence microscopy of yeast cells expressing either C-terminal GFP-tagged Zap1 with ZAP1 
promoter or N-terminal GFP-tagged zap1-C with CYC1 promoter. Cells were grown exponentially in SC 
medium at 30°C and images were taken using a fluorescence microscopy. (B) Localization of nuclear or 
cytoplasmic zap1-C. zap1-C under the control of the CYC1 promoter was fused to the SV40 bipartite NLS 
(zap1-C-NLS, KRPAATKKAGQAKKKK) or to the PKI NES (zap1-C-NES, LALKLAGLDI) and integrated to the 
LEU2 locus. Cells were grown exponentially in SC medium at 30°C and images were taken using a 
fluorescence microscopy. (C) Cells expressing either the nuclear zap1-C-NLS or cytoplasmic zap1-C-NES 
with His-Strep-tagged or untagged Urm1 were treated with 10 mM NEM for 1h at 30°C. HisStrepUrm1 was 
purified using a denaturing Ni-NTA pull-down to detect urmylated zap1-C variants. zap1-C-NLS KR and zap1-
C-NES KR possess a K871R mutation. Samples were subjected to immunoblotting using Urm1-specific 
antibodies to detect HisStrepUrm1 and anti-GFP antibodies to detect zap1-C. Dpm1 levels serve as a loading 
control. The asterisk denotes a cross-reactive band. 
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looked for the localization of the GFPzap1-C (Fig. 3-8A). Similar to full-length 
Zap1GFP, GFPzap1-C was predominantly localized in the cytoplasm as speckled 
dots and was rarely found in the nucleus. This finding coincided with recent 
screens for subcellular localization of proteins (Chong et al., 2015 and Koh et al., 
2015). In these studies, Zap1 was predominantly localized in the cytoplasm under 
steady-state conditions. Since Zap1HA and GFPzap1-C share an analogous 
nucleocytoplasmic localization, we wondered whether urmylation takes place in 
the nucleus, cytoplasm or in both compartments. To this end zap1-C variants were 
constructed that would be exclusively localized to the nucleus or in the cytosol. 
Therefore we fused SV40 bipartite nuclear localization signal (NLSSV40, 
KRPAATKKAGQAKKKK) or the protein kinase inhibitor nuclear export signal 
(NESPKI, LALKLAGLDI) to the C-terminus of zap1-C (Fig. 3-8B). All these reporter 
constructs were under the control of the CYC1 promoter and were integrated to the 
LEU2 locus. While GFPzap1-C-NLS was largely localized to the nucleus, GFPzap1-
C-NES was homogenously distributed throughout the cells (Fig. 3-8C). To 
evaluate whether the nuclear or cytoplasmic GFPzap1-C variant was urmylated, 
cells expressing HisStrepUrm1 and GFPzap1-C-NLS or GFPzap1-C-NES were 
subjected to denaturing Ni-NTA pull-down of HisStrepUrm1. Both cytoplasmic 
GFPzap1-C-NES and nuclear GFPzap1-C-NLS were urmylated (Fig. 3-8C). 
 
3.3  Function of Zap1 urmylation 
3.3.1  Zap1 stabil i ty is increased in the presence of 
Zap1 urmylation 
After showing that Urm1 covalently modifies Zap1 in the cytoplasm we studied the 
cellular consequence of Zap1 urmylation. Initially, we could observe that Zap1 
urmylation correlates with Zap1 protein levels. We already showed that this was 
partially due to increased transcription activity (Fig. 3-3B and Fig. 3-4AB). We now 
analyzed whether urmylation could have an additional effect on protein stability. To 
this end, we constructed yeast strains that express Zap1HA under the control of the 
constitutive CYC1 promoter that lacked the ZAP1 ZRE in the sequence upstream 
of the CYC1 promoter and that were integrated to the LEU2 locus. To test whether 
urmylation stabilizes Zap1, we first investigated degradation kinetics of full-length 
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Zap1HA under the control of the CYC1 promoter by utilizing the cycloheximide 
(CHX) shut-off method in WT, Δurm1 and Δuba4 cells (Fig. 3-10A). In contrast to 
WT cells, Zap1HA was degraded with slightly faster kinetics in cells lacking Urm1 
and Uba4. Since GFP is a very stable protein that is resistant to proteases and 
ubiquitin-dependent degradation, putative degrons were frequently fused to GFP in 
order to destabilize the GFP-fusion protein (Chalfie et al., 1994 and Li et al., 1998). 
Therefore, we examined the degradation kinetics of GFP and GFPzap1-C. Since 
GFPzap1-C was urmylated at K871, the degradation kinetics of GFPzap1-C-K871R 
was tested as well (Fig. 3-10B). Though, GFPzap1-C was degraded over time, 
GFPzap1-C degradation kinetics was slower than full-length Zap1HA. In absence of 
urmylation (GFPzap1-C Δurm1 and GFPzap1-K871R) GFPzap1-C was degraded with 
faster kinetics. Since the Zap1HA and zap1-CGFP degradation in absence of 
urmylation was marginally faster, we wondered if the non-urmylated nuclear Zap1 
pool masks the urmylated cytoplasmic pool of Zap1. 
 
 
Figure 3-10. Zap1 is degraded with faster kinetics in absence of urmylation. 
(A) Degradation kinetics of Δurm1 and Δuba4 cells expressing Zap1HA under the control of the constitutive 
CYC1 promoter. Exponentially grown cells incubated in YPD at 30°C were treated with CHX to inhibit 
translation. Samples were then taken after the indicated time points and subjected to immunoblotting using 
anti-HA antibodies to detect Zap1HA. Dpm1 levels serve as a loading control. (B) WT and Δurm1 expressing 
GFP, GFPzap1-C or GFPzap1-C-K871R under the control of the constitutive CYC1 promoter were incubated in 
YPD at 30°C. CHX was added to the cultures to inhibit translation. Samples were then taken after the 
indicated time points and subjected to immunoblotting using anti-GFP antibodies to detect GFP, GFPzap1-C 
and GFPzap1-C-K871R, respectively. Pgk1 levels serve as a loading control. 
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To investigate the degradation kinetics of the non-urmylated nuclear pool and the 
urmylated cytoplasmic Zap1 pool, we utilized the CHX shut-off experiment to study 
the degradation kinetics of GFPzap1-C-NLS (Fig. 3-11A) and GFPzap1-C-NES (Fig. 
3-11B). Initial experiments show that GFPzap1-C-NLS and GFPzap1-C-K871R-NLS 
were stable over a period of ≥4h in all cell lines (data not shown). Cells expressing 
GFPzap1-C-NES and GFPzap1-C-NES K871R were rapidly degraded within 30 min. 
We therefore shortened the CHX shut-off experiment and examined the 
degradation kinetics of both constructs within 25 min. While GFPzap1-C-NLS was 
stable over time, full-length GFPzap1-C-NES was rapidly and completely degraded 
into a shorter N-terminal degradation intermediate at 25 min. Remarkably, 
GFPzap1-C-NES K871R degraded even faster than GFPzap1-C-NES indicating that 
Zap1 urmylation enhances Zap1 stability. 
 
 
Figure 3-11. Zap1 C-terminus contains a cytoplasmic, Urm1-dependent degron. 
(A) Cells expressing GFPzap1-C-NLS and GFPzap1-C-NLS K871R under the control of the constitutive CYC1 
promoter were incubated in YPD at 30°C. CHX was added to the cultures to inhibit translation. Samples were 
then taken after the indicated time points and subjected to immunoblotting using anti-GFP antibodies to detect 
GFPzap1-C-NLS and GFPzap1-C-NLS K871R, respectively. Dpm1 levels serve as a loading control. (B) Cells 
expressing GFPzap1-C-NES and GFPzap1-C-NES K871R under the control of the constitutive CYC1 promoter 
were incubated in YPD at 30°C. CHX was added to the cultures to inhibit translation. Samples were then taken 
after the indicated time points and subjected to immunoblotting using anti-GFP antibodies to detect GFPzap1-C-
NES and GFPzap1-C-NES K871R. Dpm1 levels serve as a loading control. 
 
Prior experiments showed that overexpression of Urm1 not only leads to an 
increase in free Urm1, but also an overall increase in Urm1-conjugates (data not 
shown). Urmylation significantly increased when replacing the endogenous URM1 
promoter to the inducible GAL1 promoter (Fig. 3-12A). We therefore asked 
whether a pulse of galactose-induced Urm1 would increase the overall Zap1HA by 
putatively increasing the urmylated Zap1 pool. To this end, we utilized cells 
expressing Zap1HA under the CYC1 promoter together with the inducible Urm1 
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elevated in galactose-induced cells (Fig. 3-12A). Hence, we speculated that the 
elevated Zap1HA level was due to Zap1 urmylation triggered by a burst of 
galactose-induced Urm1 expression. To exclude that the elevated Zap1HA level in 
presence of galactose-induced Urm1 was due to improved Zap1 transcription or 
translation, we utilized the CHX shut-off experiment to determine Zap1HA 
degradation kinetic of cells, which were grown either with (+) or without (-) 
galactose for 3h at 30°C (Fig. 3-12B). Intriguingly, while Zap1HA was entirely  
 
 
Figure 3-12. Elevated Urm1 levels lead to Zap1 stabil ization. 
(A) Overview of Urm1 under the control of the inducible GAL1 promoter. Upon galactose-induced 
overexpression of Urm1 Zap1HA protein levels are elevated. Cells expressing Zap1HA and Urm1 under the 
control of the inducible GAL1 promoter were grown exponentially in YPR for 4.5h. Galactose was added to the 
medium and incubated for 3h to induce Urm1. Samples were collected and subjected to immunoblotting using 
anti-HA antibodies and Urm1-specific antibodies to detect Zap1HA and Urm1, respectively. (B) Zap1 
degradation rate is decreased in presence of elevated Urm1 levels. Cells expressing Zap1HA and Urm1 under 
the control of the inducible GAL1 promoter were grown exponentially in YPR for 4.5h. Galactose was added to 
the medium and incubated for 3h to induce Urm1. CHX was then added to the cultures to inhibit translation. 
Samples were then taken after the indicated time points and subjected to immunoblotting using anti-HA 
antibodies and Urm1-specific antibodies to detect Zap1HA and Urm1, respectively. Pgk1 levels serve as a 
loading control. Quantification of Zap1 degradation kinetics and half-life are shown below. Values are mean for 
n=2. 
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degraded after 90 min in cells grown without galactose (-Gal half-life t1/2=14.3 
min), Urm1-inducing cells showed a notable delay in Zap1HA degradation kinetics 
(+ Gal half-life t1/2=48.6 min) (Fig. 3-12B). This finding suggests that a short 
overexpression of Urm1 was able to protect Zap1HA from degradation. 
 
3.3.2  Ubiquit in proteasome-dependent degradation of 
Zap1 
As shown previously, Zap1 is a highly unstable protein that is rapidly degraded in 
an Urm1-dependent manner. We therefore investigated the nature of Zap1 
degradation in order to understand how Zap1 urmylation could positively influence 
Zap1 stability. Earlier studies showed that yeast cells carrying the heat-sensitive, 
proteasomal mutant cim3-1 grown under restrictive temperatures caused a cell 
cycle arrest at G2/M and an accumulation of proteasomal substrates (Ghislain et 
al., 1993). To investigate if degradation of Zap1 is proteasomal dependent, the 
degradation kinetics of Zap1HA under the constitutive CYC1 promoter were tested 
in WT, cim3-1 and Δurm1 cim3-1 cells (Fig 3-13). Zap1HA expressed in cim3-1 and 
cim3-1 Δurm1 was strongly stabilized. We therefore conclude that degradation of 
Zap1 is mediated via the proteasome. To assess, if the proteasomal degradation 
of Zap1 was mediated by Zap1 ubiquitination, we examined whether the C-
terminus of Zap1 was polyubiquitinated. Using an immunoprecipitation (IP) method 
to purify GFP and GFPzap1-C, the eluates were probed with anti-ubiquitin 
antibodies (Fig. 3-14A). We could detect faint bands of ubiquitin in mock and GFP 
samples, whereas several higher migrating bands corresponding to ubiquitinated  
 
 
Figure 3-13. Zap1 is degraded via the ubiquit in-proteasome system. 
WT, cim3-1 and cim3-1 Δurm1 expressing Zap1HA under the control of the constitutive CYC1 promoter were 
first grown to log phase at 25°C and incubated under the non-permissive temperature of 37°C for 1.5h to 
functionally inactivate the proteasome in cim3-1 cells. CHX was added to the cultures to inhibit translation. 
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Samples were then taken after the indicated time points and subjected to immunoblotting using anti-HA 
antibodies to detect Zap1HA. Pgk1 levels serve as a loading control.  
 
species were detected in the immunoprecipitated GFPzap1-C sample indicating that 
the C-terminus of Zap1 is ubiquitinated. Next, GFPzap1-C-NLS and GFPzap1-C-NES 
were immunoprecipitated under denaturing conditions and probed for ubiquitin 
using anti-ubiquitin antibodies (Fig. 3-14B). Compared to GFPzap1-C-NLS, a high 
amount of ubiquitin was co-immunoprecipitated with GFPzap1-C-NES. Since we 
could not IP GFPzap1-C-NES in equimolar amounts among all strains, we were 
unable to conclusively discern whether Zap1 urmylation influences Zap1 
ubiquitination in this experimental setup. 
 
 
Figure 3-14. GFPzap1-C and the cytoplasmic GFPzap1-C-NES are strongly ubiquitylated. 
(A) WT cells (mock) and cells expressing GFP or GFP-tagged zap1-C were grown exponentially in YPD at 
30°C and subjugated to immunoprecipitation of GFP and GFPzap1-C using GFP-Trap. Samples were subjected 
to immunoblotting using anti-GFP antibodies to detect GFP and GFPzap1-C and anti-ubiquitin antibodies to 
detect ubiquitinated substrates. (B) Cytoplasmic GFPzap1-C-NES is strongly ubiquitylated, but not the nuclear 
GFPzap1-C-NLS. WT cells (mock) and WT, Δurm1, Δuba4, cells expressing either GFP, GFPzap1-C-NES, 
GFPzap1-C-NLS or their respective KR mutant counterparts, were grown exponentially in YPD at 30°C and 
subjugated to immunoprecipitation of GFP and GFPzap1-C using GFP-Trap. Samples were subjected to 
immunoblotting using anti-GFP antibodies to detect GFP, GFPzap1-C-NES and GFPzap1-C-NLS. Anti-ubiquitin 
antibodies were used to detect ubiquitinated substrates. 
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3.3.3  Identif ication of a Zap1-specif ic E3 l igase 
As GFPzap1-C and the cytoplasmic GFPzap1-C-NES were shown to be highly 
ubiquitinated, we sought to identify the responsible E3 ligase. For this reason, we 
immunoprecipitated GFPzap1-C and GFPzap1-C-K871R (Fig 3-15, left) and 
investigated samples by LC-MS/MS analysis (Fig 3-15, right). Due to a 
contamination of the GFPzap1-C-K871R sample with GFPzap1-C proteins possibly 
during sample preparation, an examination on the differences between both 
samples was not possible. Nonetheless, the interaction partners of GFPzap1-C 
could be analyzed using immunoprecipitated GFPzap1-C samples after a LC-
MS/MS analysis. Alongside the identification of Urm1 and Uba4, we could co-
purify most of the Doa10 complex (i.e. Doa10, Cue1, Rad23, Ubx2, Ufd2, Npl4 and 
Cdc48) in the GFPzap1-C samples. Interestingly, it was previously shown that the 
E3 ligase Doa10 together with the ER-associated intramembrane protease Ypf1 
and the ERAD-factor Dfm1 could recognize and degrade the Zap1-target gene 
ZRT1 in a zinc-dependent manner (Avci et al., 2014). In order to verify that the 
 
Figure 3-15. Putative interaction partners of zap1-C. 
WT cells (mock) and cells expressing GFP-tagged zap1-C or zap1-C-KR under the control of MET25 promoter 
were immunoprecipitated using GFP-Trap to immunoprecipitate zap1-C or zap1-C-KR (left panel). Samples 
were collected and a fraction was subjected to immunoblotting using anti-GFP antibodies to detect zap1-C. 
The remaining sample was subjected to LC-MS/MS analysis. A list of selected, putative zap1-C interaction 
partners were listed with their respective peptide intensities (right). 
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Doa10 complex was responsible for mediating the ubiquitin-dependent 
degradation of Zap1; we examined the degradation kinetics of WT, Δdoa10 and 
cdc48-3 cells expressing Zap1 under the control of the constitutive CYC1 promoter 
using the CHX shut-off method (Fig. 3-16A). Degradation of Zap1HA in cells lacking 
Doa10 and in cdc48-3 cells was either delayed or completely abolished, 
respectively. Analogously, we tested if the delay in Zap1HA degradation in Δdoa10 
and cdc48-3 cells could be attributed to defective degradation of the cytoplasmic 
Zap1 pool. We therefore utilized the CHX shut-off experiment to monitor the 
degradation kinetic of GFPzap1-C-NES in WT, Δdoa10 and cdc48-3 cells (Fig. 3-
16B). GFPzap1-C-NES degradation was completely blocked in Δdoa10 and strongly 
delayed in cdc48-3 cells. Intriguingly, GFPzap1-C-NES was completely stabilized in 
Δdoa10 cells. These data clearly indicate that the degradation process of 
cytoplasmic Zap1 works via a Doa10 and Cdc48 dependent pathway. 
 
 
Figure 3-16. Doa10 and Cdc48 mediate the degradation of Zap1 and zap1-C.  
(A) WT, Δdoa10, cdc48-3 cells expressing Zap1HA under the control of the constitutive CYC1 promoter were 
first grown at room temperature to reach logarithmic phase of growth. Prior CHX addition, the cells were 
incubated for 2h at non-permissive temperature (37 °C). Samples were then taken after the indicated time 
points and subjected to immunoblotting using anti-HA antibodies to detect Zap1HA. Pgk1 levels serve as a 
loading control. (B) WT, Δdoa10, cdc48-3 cells expressing GFPzap1-C under the control of the constitutive 
CYC1 promoter were first grown at room temperature to reach logarithmic phase of growth. Prior CHX 
addition, the cells were incubated for 2h at non-permissive temperature (37 °C). Samples were then taken 
after the indicated time points and were prepared by the TCA method and subjected to immunoblotting using 
anti-GFP antibodies to detect GFPzap1-C. Pgk1 levels serve as a loading control. 
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4  Discussion 
Despite recent studies about the importance of Urm1 as a sulphur carrier by 
thiolating U34 in wobble tRNALys(UUU), tRNAGln(UUG), and tRNAGlu(UUC), little is known 
about Urm1 as a post-translational protein modifier. Though a few Urm1 
substrates have been identified, the precise role of urmylation on these Urm1-
modified substrates have yet to be elucidated. 
In this thesis, we developed a quantitative proteomic approach to identify novel 
Urm1 substrates. We could reproducibly recognize a set of so far unknown Urm1 
protein substrates. Importantly, with this strategy we were able to detect known 
Urm1 target proteins such as Ahp1 and Uba4, and several previously unidentified 
Urm1-substrates, indicating that our MS-based protocol is a potent method for the 
detection of Urm1 target proteins. Moreover, for the first time we could detect 
respective Urm1-attachment sites in a proteomic approach confirming that Urm1 is 
indeed a lysine-directed modifier. Among this set of proteins, we could identify and 
verify the zinc-dependent transcription-activator Zap1, a master zinc regulator in S. 
cerevisiae, as a lysine-directed Urm1-substrate. Urm1 modifies Zap1 at the very 
C-terminus (even in absence of the transcriptional-activation and chromatin-
binding domain of Zap1) and seems to stabilize Zap1. Accordingly, absence of 
Zap1 urmylation made Zap1 more susceptible to ubiquitin-dependent degradation. 
While cells lacking Urm1 and Uba4 show an impaired growth under zinc-depleted 
conditions, these cells can be rescued by expressing a linearly fused zap1-
urm1ΔGG, indicating that Zap1 urmylation plays an important role under zinc 
deficiency. In line with the zinc sensitivity of cells lacking Urm1, ZAP1 expression 
and the expression of the Zap1 target gene ZRT1 are downregulated. The 
following findings and their implications will be discussed below. 
 
4.1  Strategy for the identif ication of novel Urm1-
substrates 
Deletion of the Urm1 pathway displays a plethora of stress-induced phenotypes in 
S. cerevisiae suggesting an essential role of Urm1 in stress tolerance (Furukawa 
et al., 2000; Goehring et al., 2003ab; Chen et al., 2009; Khoshnood et al., 2016; 
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Damon et al., 2015; and Schorpp, 2011). Due to the dual function of Urm1 as a 
protein modifier and its role in Urm1 tRNA thiolation it is difficult to connect a new 
identified stress-induced phenotype with a specific Urm1 activity. Many Urm1-
deficient phenotypes correlate with lack of U34 thiolation and there are no known 
phenotypes that are attributed to a lack in substrate urmylation (Leidel et al., 2009; 
data not shown). Moreover, it remains unclear, if the urmylation and sulphur donor 
function of Urm1 are functionally connected (Goehring et al., 2003b; Schorpp, 
2011; data not shown). Previous studies in S. cerevisiae, mammalian cells and D. 
melanogaster described very few urmylated substrates under steady-state 
conditions, but various oxidizing agents such as diamide, H2O2, tert-butyl 
hydroperoxide (t-BOOH) enhanced protein urmylation (Furukawa et al., 2000; 
Goehring et al., 2003a; Van der Veen et al., 2011; and Khoshnood et al., 2016). 
Treatment with diamide, H2O2 and t-BOOH yielded disparate and distinct 
urmylation patterns suggesting that these oxidizing agents trigger specific Urm1 
conjugates. An even more potent stimulant of Urm1 conjugation is N-
ethylmaleimide (NEM), which causes irreversible alkylation of free thiols (Gregory, 
1955). This in turn affects all thiol-containing proteins such as the alkylation and 
inactivation of cysteine peptidases that are able to resolve UBLs and possibly 
deurmylases. 
To understand the cellular functions of Urm1 and to maximize the amount of 
urmylated proteins in an unbiased manner, a SILAC-based quantitative proteomics 
approach was conducted in the presence of NEM, as it would potentially 
deactivate deurmylases, trapping urmylated proteins and eventually leading to the 
accumulation of Urm1-substrates. To exclude Urm1 interactors and to increase the 
amount of urmylated proteins, a denaturing Nickel-nitrilotriacetic acid (Ni-NTA) 
purification method or a denaturing tandem affinity purification (TAP) method was 
utilized. By the nature of LC-MS/MS-based sample preparation, branched 
peptides, among other things, are generated by tryptic digestion. These branched 
peptides are derived from covalently modified proteins and enable the 
identification of potential Urm1-targeted acceptor lysine residues. Since WT Urm1 
would generate Urm1 branched peptides of considerable length, the HisHAurm1-
L96R variant was used in order to generate Urm1-specific HGG-ε-K signature 
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branched peptides in a LC-MS/MS approach, which allows the recognition of 
urmylation sites (Fig. 3-2A). A total of 547 putative Urm1-substrates were identified 
in the screen using NEM-treated and untreated cells expressing HisHAurm1-L96R, 
which included the known Urm1-substrates Ahp1 and Uba4 indicating the overall 
reliability of the LC-MS/MS. Even though Urm1 and the Urm1-modified substrates 
were purified under denaturing conditions, it is still possible for high-affinity binders 
and contaminants to be co-purified (Lüders et al., 2003; and Tagwerker et al., 
2006). Since both samples contain approximately equimolar amounts of high-
affinity binders and contaminants, proteins with a H/L ratio of >1 and a p-value of 
<0.05 were inquired in order to exclude false-positives. Indeed, 21 proteins met 
the above-mentioned criteria and were significantly enriched in NEM-treated cells 
(Fig. 3-2B, Tab. 3-1). The majority of these proteins was additionally found in at 
least one of two confirmation experiments using urm1-L96R variants and was also 
identified in at least one of three experiments using WT Urm1, suggesting that 
these proteins are very likely to be true covalently modified Urm1-substrates (Tab. 
3-1). Utilizing the urm1-L96R variants proved to be advantageous, as it allowed 
the identification of Urm1-specific HGG-ε-K signature peptides, which in turn lead 
to the recognition and characterization of Urm1-attachment sites. Thus, we were 
able to identify a total of 59 Urm1-attachment sites using the urm1-L96R variant in 
the total sum of three denaturing purification experiments. Consistent with previous 
results, we were able to identify the lysine residue K32 of the peroxiredoxin Ahp1 
as the Urm1-attachment site and K41 and K107 as additional acceptor lysine (Van 
der Veen et al., 2011, data not shown). Whether urmylation of Ahp1 at K41 and/or 
K107 plays a physiological role in regulating Ahp1, remains to be shown in future 
studies. Among the Urm1-attachment sites, we were able to discover the lysine 
residue 871 of the zinc-responsive transcription factor Zap1 as Urm1 acceptor site 
and could confirm Zap1 urmylation at K871 in western blot experiments (Tab. 3-1, 
Fig, 3-7D). 
Altogether, the HisHAurm1-L96R variant appears to be an excellent tool to identify 
unknown Urm1-substrates under various conditions in a mass spectrometry 
approach. The His-tag enables Urm1-conjugates to be purified under denaturing 
conditions by preserving protein modifications, while non-covalent protein-protein 
DISCUSSION 
 
 44 
interactions are unstable under these conditions. In addition the L to R conversion 
of the urm1-L96R variant allows the identification of Urm1-attachment sites by 
trypsin digestion and creating tryptic branched peptides of Urm1-substrates that 
can be measured by LC-MS/MS. We were able to identify several unknown Urm1-
substrates and a set of Urm1-modified proteins with their respective Urm1-
attachment sites. This data could provide new insights into the role of Urm1 as a 
protein modifier. It remains to be seen if more proteins can be validated as bona 
fide Urm1-substrates and how these urmylated proteins impact cells in vivo. 
 
 
4.2  Urm1 modif ies Zap1 
In this work, we identified the zinc-responsive transcription factor Zap1 as a novel 
lysine-directed Urm1-substrate using LC-MS/MS and validated Zap1 urmylation by 
the denaturing tandem affinity purification (TAP) method. As previously shown, 
substrate urmylation requires the presence of the E1-like enzyme Uba4 and an 
acceptor lysine within the target protein (Furukawa et al., 2000; and Van der Veen 
et al., 2011). To investigate whether Zap1 urmylation is dependent on the 
enzymatic activity of Uba4 and requires the acceptor lysine K871, Δuba4 Zap1HA 
and zap1 K871RHA strains were created in HisStrepUrm1 background. However, 
Zap1HA was unstable in these strains compared to Zap1HA in Wt cells making it 
challenging to investigate Zap1 urmylation in these strain backgrounds. To 
examine whether the decrease in Zap1 levels stems from the influence of Zap1 
urmylation on the transcriptional activity of Zap1, the endogenous ZAP1 promoter 
was replaced to various constitutive (CYC1, ADH1) and inducible promoters 
(MET25, GAL1) in order to discontinue Zap1 binding to ZAP1 ZRE and hence 
uncoupling the autoregulatory Zap1 mechanism. Yet, Zap1 levels remained 
decreased in absence of Urm1, Uba4 or in cells expressing zap1-K871RHA 
indicating that Urm1-conjugation to Zap1 does not influence the transcriptional 
activity of Zap1, but may improve Zap1 stability (data not shown). By fusing the 
last 64 aa of Zap1 (zap1817-880, zap1-C) to GFP, we were able to obtain a GFP 
reporter that was more stable than Zap1HA and thus could be used in Δuba4 
strains and in cells expressing GFPzap1-C-K871R. Remarkably, the Urm1 
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conjugation machinery was able to recognize the short Zap1-specific sequence of 
GFPzap1-C and urmylate GFPzap1-C in an Uba4-dependent manner. Moreover, 
urmylation clearly depends on presence of lysine K871 of Zap1, as GFPzap1-C-
K871R was no longer urmylated. Zap1 seems to be specifically mono-urmylated at 
K871 although the C-terminal part of Zap1 and zap1-C contains multiple lysine 
residues. Zap1 (and zap1-C variant) urmylation only affects a small fraction of the 
total Zap1 pool independent of Zap1 expression and intracellular zinc 
concentrations (data not shown). This observation is especially peculiar, as the 
zap1-C variants are overexpressed under constitutive promoters like CYC1 and 
ADH1 indicating that the urmylated Zap1 pool is being tightly regulated. Whether 
this observation stems from a transient Zap1 urmylation and subsequent 
deurmylation or from an unknown trigger that potentiates or down regulates Zap1 
urmylation is unclear. 
 
4.2.1  Localization of Zap1-Urm1 
To gain more insights into the function of Zap1 urmylation, we studied the cellular 
localization of urmylated Zap1. Unlike previous publications showing mycZap1 
under the control of GAL1 promoter to be localized to the nucleus, we showed that 
endogenously expressed Zap1GFP was predominantly localized to the cytoplasm 
and was rarely observed in the nucleus under zinc-replete conditions (Bird et al., 
2000, Fig. 3-8A). The discrepancy in localization of overexpressed mycZap1 and 
endogenously expressed Zap1GFP could be explained by preceding studies that 
showed that overexpressed Zap1 was constitutively bound to ZRT1 ZREs, (and 
possibly other ZREs), independent of the cellular zinc concentration (Frey et al., 
2011). The constitutive binding of mycZap1 to the chromatin could explain prior 
observations of a predominant nuclear mycZap1, as overexpression of Zap1 seems 
to bypass the zinc-sensing ability of Zap1 and possibly enabling the translocation 
of Zap1. As our data concurred with recent screens for subcellular localization of 
yeast proteins, in which endogenous Zap1GFP showed a predominantly 
cytoplasmic localization under zinc-replete conditions (Chong et al., 2015; and Koh 
et al., 2015), it is likely that Zap1 is retained in the cytoplasm under zinc-replete 
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conditions and translocated to the nucleus under zinc deficiency; a regulatory 
mechanism commonly observed with conditional transcription factors that are 
retained in the cytoplasm, but translocated to the nucleus in response to external 
stimuli (Johnson et al., 1999; Yamaguchi-Iwai et al., 2002; Cox et al., 2004; and 
Lindert et al., 2009). In fact, a recent study demonstrated that zinc-starvation 
promoted the gradual nuclear translocation of Zap1 over time (Kawamata et al., 
2017). Since GFPzap1-C is recognized by the Urm1 conjugation machinery and 
shows a similar cellular localization of full-length Zap1, we used this GFPzap1-C 
version to fuse it to sequences targeting GFPzap1-C either to the nucleus via a 
nuclear localization signal (NLS) or cytoplasm via a nuclear export signal (NES). 
Both GFPzap1-C-NES and GFPzap1-C-NLS predominantly localized into their 
intended cellular compartments. We could demonstrate that the cytoplasmic 
GFPzap1-C-NES and nuclear GFPzap1-C-NLS was urmylated. While ScUrm1 and 
hUrm1 are localized ubiquitously distributed within cells, ScUba4 and hUba4 are 
strictly located at the cytoplasm (Chowdhury et al., 2012; Chong et al., 2015 and 
Koh et al., 2015). However, subcellular fractionation of human cells showed that 
free hUrm1 and conjugated hUrm1-substrates alike are solely found in the 
cytoplasm (Van der Veen et al., 2011). In line with this finding, Drosophila Urm1 is 
exclusively localized at the cytoplasm (Khoshnood et al., 2016). How is the 
predominantly nuclear GFPzap1-C-NLS still being recognized and urmylated by the 
cytoplasmic-localized Urm1-conjugation machinery? The urmylation machinery 
might target the newly translated and cytoplasmic GFPzap1-C-NLS pool. Thus, a 
small fraction of GFPzap1-C-NLS is being urmylated. Together, the localization 
studies done on the Urm1 machinery and the Urm1 conjugates as well as our data 
on GFPzap1-C-NES/NLS urmylation point to the urmylation of the cytoplasmic Zap1 
pool. 
 
4.2.2  Role of Zap1 urmylation 
Thus far, accumulation of Urm1-modified proteins was observed upon oxidative 
stress implying a contribution of protein urmylation in the defense against reactive 
oxygen species (ROS). Another contributor for preserving the intracellular redox 
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homeostasis is zinc (Powell, 2000). It is believed that zinc exerts its antioxidant 
properties by complexation with sulfhydryl groups, which prevents ROS-induced 
oxidation and thus preventing formation of aberrant disulfide bonds (Eide, 2011; 
and Jarosz et al. 2017). Consequently, zinc deficiency elevates the intracellular 
ROS level, resulting in a higher susceptibility to ROS-induced cellular damages 
(Oteiza et al., 2000; Ho & Ames, 2002; Wu et al., 2007; and Wu et al., 2009). The 
zinc-dependent transcription factor Zap1 is able to counteract zinc deficiency by 
activating zinc transporters that facilitate zinc influx (Zhao & Eide, 1996, 1997). 
Additionally, Zap1 activates the expression of the thioredoxin peroxidase Tsa1 and 
the cytosolic catalase Ctt1 (Wu et al., 2007, 2009). These two proteins play a 
pivotal role in protecting cells from ROS under low zinc conditions. In zinc limiting 
conditions, sulphur assimilation is repressed in a Zap1-dependent manner (Wu et 
al., 2009). Since both sulphur assimilation and combating oxidative stress require 
large amounts of NADPH, Zap1-dependent repression of the sulphur assimilation 
pathway results in a higher availability of NADPH to combat oxidative stress 
(Slekar et al., 1996; and Eide, 2009). Consequently, we investigated the role of the 
Urm1 pathway under zinc deficiency. Remarkably, lack of Urm1 and/or Uba4 
caused sensitivity towards cells grown under zinc-limiting conditions, whereas 
supplementing the medium with zinc reversed the growth defects. These data 
suggest that the observed growth defects are linked to zinc deficiency and/or its 
subsequent induction of oxidative stress. In addition, Urm1 adducts appeared in 
response to zinc deficiency, indicating that the protein-conjugation branch of Urm1 
might play an important role in combating the adversary effects of zinc deficiency. 
Which proteins are urmylated, how urmylation of these substrates benefit cells 
under zinc-limiting conditions and whether the sulphur-donor branch of Urm1 acts 
synergistically under low zinc remains an open question. 
Under zinc-limiting condition, ZAP1 expression was significantly reduced in cells 
lacking urmylation, as both cells expressing Δurm1 and zap1-K871R showed a 
comparable reduction in ZAP1 mRNA, indicating that Zap1 urmylation improves 
the transcriptional fidelity of Zap1 and is therefore detrimental in maintaining the 
transcriptional autoregulation of ZAP1. As a consequence of the decreased ZAP1 
expression, protein levels of Zap1 were reduced in both Δurm1 and zap1-K871R. 
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Furthermore, the reduction in ZAP1 expression resulted in a mild reduction of the 
downstream target ZRT1, which is the primary zinc transporter in S. cerevisiae 
that is activated upon zinc deficiency. As this reduced ZRT1 expression is most 
likely a secondary effect caused by a reduced ZAP1 transcription in absence of 
Zap1 urmylation, it is likely that more ZAP1 downstream targets are negatively 
affected by loss of Zap1 urmylation. As Zrt1 levels were reduced in Δurm1 and 
Δuba4 cells, loss of Zap1 urmylation may impair Zap1’s function in zinc 
homeostasis (data not shown). To test whether Zap1 urmylation improves cell 
growth on zinc-limiting conditions, we also tested growth of cells that did not 
express endogenous Zap1, but the linear fused zap1-urm1ΔGG. This variant was 
used to mimic a constitutively urmylated Zap1 variant. Intriguingly, cells expressing 
a zap1-urm1ΔGG fusion, but lacking Urm1 or Uba4, were able to grow like or 
perhaps even slightly better than WT cells expressing zap1-urm1ΔGG or under 
zinc-limiting conditions. However, cells expressing zap1-urm1ΔGG lacking Urm1 
and Uba4 showed growth impairment or no growth under t-BOOH induced 
oxidative stress. This result implies that Zap1 urmylation seems to be vital in 
restoring Zap1 function in zinc homeostasis, but does not contribute in ROS 
defense. In contrast, cells expressing zap1-K871R showed no growth defects 
under the above-mentioned conditions. How zap1-K871R is able to grow on zinc-
limiting conditions, but Δurm1 does not, remains ambiguous. A possible 
explanation for this discrepancy is that Urm1 could conjugate to neighboring lysine 
residues of Zap1, though no urmylation could be observed with cells expressing 
GFPzap1-C-K871R and GFPzap1-C-NES-K871R. Another possible explanation is 
that Urm1 modifies additional target proteins that are involved in zinc homeostasis, 
enabling these urmylated substrates to compensate the reduced functionality of 
unmodified Zap1/zap1-K871R (Fig. 3-5). Conversely, the rescue of cells lacking 
Urm1 and Uba4 with the expression of the Zap1-Urm1 fusion zap1-urm1ΔGG 
could stem from the fact that the entire Zap1 pool is constitutively urmylated, which 
might drastically enhance overall activity of Zap1 that in turn allows a more 
efficient response to zinc deficiency. In addition, zap1-urm1ΔGG could even carry 
out additional cellular functions that are advantageous during low zinc conditions. 
Prior studies showed that fusion of ubiquitin-like proteins (UBLs) such as SUMO or 
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ubiquitin to proteins could indeed mimic a UBL-modified form of the target protein 
and therefore results in a change of the target protein’s properties, such as an 
increase in stability and solubility (SUMO, Malakhov et al., 2004; and Wang et al., 
2010) or in the destabilization of the fused protein (ubiquitin, Bachmair et al., 1986; 
and Cadima-Couto et al., 2009). Indeed, zap1-urm1ΔGG levels and zap1-K871R-
urm1ΔGG between WT and Δurm1, but not Δuba4, were comparable and could 
indicate to a more stabilized Zap1 variant than WT Zap1 (Fig. 3-6B). However, 
further studies are required to assess whether zap1-urm1ΔGG is indeed more 
stable than Zap1. 
Concordant to the observed reduction of ZAP1 mRNA in cells lacking the ability to 
urmylate Zap1, we could consistently observe noticeable reduction in Zap1 levels 
in cells lacking urmylation. This phenomenon persisted in cells lacking Urm1, 
Uba4 expressing Zap1 or in cells expressing zap1-K871R under constitutive 
promoters such as CYC1, which uncouples the autoregulatory mechanism of Zap1 
and enables Zap1-indepdendent, constitutive ZAP1 expression (Fig. 3-10A, data 
not shown). These findings indicate that Zap1 urmylation positively affects Zap1 
stability, but not the transcriptional activity of Zap1. Since zap1-K871R protein 
levels were reduced as well and is unlikely to alter the activity of the URM1 
pathway, it is improbable that the Urm1-dependent tRNA modification branch has 
an effect on Zap1 translation and consequently on Zap1 protein level. Since the 
translation of a subset of genes enriched for AAA, CAA and GAA codons is 
impaired in absence of Urm1- and ELP-dependent tRNA modification of tKUUU, 
tQUUG, tEUUC (Rezgui et al., 2013 and Laxman et al., 2013), we examined if ZAP1 
mRNA is enriched with these above-mentioned codons. In silico analyses done by 
Rezgui et al. show that ZAP1 is not significantly enriched in the codons AAA, CAA 
and GAA, indicating that the translation of Zap1 is probably not impaired in 
absence of Urm1-dependent tRNA modification (Rezgui et al., 2013). 
Since Zap1 urmylation positively influences Zap1 levels, it is possible that Urm1-
modified Zap1 species are less prone to degradation compared to unmodified 
Zap1. Thus, the role of Zap1 urmylation could be to maintain a constant pool of 
Zap1 that is able to rapidly respond to Zap1-dependent environmental stressors. 
Intriguingly, degradation of full-length Zap1 was not dramatically accelerated in 
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absence of Zap1 urmylation, even though the overall protein levels of Zap1 were 
largely reduced. This observation might be blurred by the fact that only a small 
percentage of the overall Zap1 is urmylated. A way to potentiate urmylation would 
be to increase Urm1 expression, as Urm1 is low abundant under steady-state 
conditions (Ghaemmaghami et al., 2003; and Chong et al., 2015). Indeed, free 
Urm1 and Urm1 adducts increased when Urm1 was expressed under the GAL1 
promoter than Urm1 expressed under the constitutive ADH1 promoter (Fig. 3-
12A). Consequently, strong overexpression of Urm1 could be used to increase the 
urmylated Zap1 pool, which in turn would facilitate to study the effect of elevated 
Zap1 urmylation in cells. Indeed, when Urm1 was overexpressed using the 
galactose-inducing system, we could observe a markedly increase in Zap1HA level 
and slowed Zap1HA degradation compared to the accelerated Zap1 degradation 
kinetics in cells, which had no galactose-induction and consequently no Urm1 
expression (Fig. 3-12B). Even though these findings suggest that Zap1 urmylation 
antagonizes Zap1 degradation, it has yet to be assessed whether there is indeed 
an increase in Zap1 urmylation under the GAL induction system than in WT cells. 
Since Zap1 urmylation exclusively occurs in the cytoplasm under zinc-replete 
conditions, a way to monitor a larger pool of urmylated Zap1 would be to examine 
the degradation kinetics of cytoplasmic Zap1. Consequently, we looked for the 
degradation kinetics of the cytoplasmic GFPzap1-C-NES, which we have shown to 
be recognized by the Urm1 conjugation machinery and urmylated at the acceptor 
lysine K871, and compared the degradation kinetics to the non-urmylated nuclear 
GFPzap1-C-NLS. While the nuclear GFPzap1-C-NLS was very stable, GFPzap1-C-
NES was rapidly degraded (Fig. 3-11). Compared to GFPzap1-C-NES, degradation 
of the non-urmylated GFPzap1-C-NES-K871R variant was highly accelerated; 
indicating that Zap1 urmylation positively influences the stability of cytoplasmic 
Zap1 (Fig. 3-11B). A way to further verify the positive effect of Urm1 on Zap1 
stability would be to examine the degradation kinetics of full-length Zap1 in the 
cytoplasm and compare it to the stability of nuclear Zap1. Despite these findings, 
the exact mechanism by which Urm1 is able to antagonize Zap1 degradation is not 
entirely clear. Prior studies have shown that the otherwise stable GFP can be 
susceptible to degradation by fusing GFP to a degron (Li et al., 1998). Various 
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degrons consist of a short amino-acid sequence such as the Deg1 of Matα2 or 
CL1 and are able to destabilize various reporter proteins (Hochstrasser & 
Varshavsky, 1990, Hochstrasser et al., 1991, Chen et al., 1993 and Gilon et al., 
1998). Peculiarly, only cytoplasmic Zap1 seems to be highly susceptible to 
degradation, suggesting that the C-terminus sequence of Zap1 contains a degron, 
which is exclusively recognized in the cytoplasm. While various degrons are 
degraded independent to their respective subcellular localization, the ubiquitously 
localized Cdc5 appears to be efficiently degraded in the nucleus (Bennett et al., 
2005; and Arnold et al., 2015). Similarly, the C-terminal Zap1 degron seems to be 
solely recognized in the cytoplasm. We have shown that GFPzap1-C and the 
cytoplasmic GFPzap1-C-NES as well as GFPzap1-C-K871R-NES, but not GFPzap1-C-
NLS and GFPzap1-C-K871R-NLS, were highly ubiquitinated and that full-length 
Zap1 degradation was halted in the proteasomal mutant cim3-1 (Fig. 3-14AB, Fig. 
3-13). Moreover, GFPzap1, GFPzap1-C-NES and GFPzap1-C-K871R-NES were highly 
ubiquitinated, whereas GFPzap1-C-NLS and GFPzap1-C-K871R-NLS were not 
modified by ubiquitin (Fig. 3-14AB). As GFPzap1-C-K871R-NES was more 
susceptible to proteasomal degradation than GFPzap1-C-NES, non-urmylated 
GFPzap1-C-NES in cells lacking Urm1 and Uba4 and GFPzap1-C-K871R-NES 
should be ubiquitinated more. However, the comparison of ubiquitination between 
GFPzap1-C-NES expressed in WT, Δurm1 and Δuba4, as well as GFPzap1-C-
K871R-NES expressed in WT, was no possible as overall protein levels and pull-
down efficiency of GFPzap1-C-NES and GFPzap1-C-K871R-NES in cells lacking 
urmylation were significantly lower than GFPzap1-C-NES expressed in WT (Fig. 3-
11, 3-14B). Therefore, further ubiquitination experiments using equimolar amounts 
of purified GFPzap1-C-NES and GFPzap1-C-K871R-NES are needed to assess Zap1 
ubiquitination in presence and absence of urmylation. 
Taken together, these findings suggest Zap1 is degraded via the proteasome and 
indicate that the C-terminus contains an ubiquitin-dependent cytoplasmic degron. 
As the ubiquitin-dependent Zap1 degradation occurs in the cytoplasm, we 
searched for potential E3 ligases that could be responsible for the ubiquitination of 
Zap1. We were able to identify most of the E3 ubiquitin ligase complex Doa10 as 
interaction partners in a mass spectrometry approach. Furthermore we could show 
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that the degradation of Zap1 is slowed down or completely halted in Δdoa10 and 
cdcd48-3 cells expressing Zap1HA or zap1-C-NES, respectively. It remains to be 
seen, whether the binding of Doa10 to Zap1 and its consequent ubiquitination is 
countered by Zap1 urmylation. Taken together our data suggest that urmylation 
and ubiquitination of Zap1 are interconnected and serve as disparate mechanisms 
in regulating Zap1 – and also Zap1 transcription – on a posttranslational level. 
Urm1 might function as an antagonist of ubiquitin and ubiquitination of Zap1, 
similar to the proposed role of IκBα SUMOylation (Desterro et al., 1998). In this 
study, the authors showed that SUMOylation and ubiquitination of IκBα occur at 
the same acceptor lysine (K21) and that SUMOylated IκBα is resistant to TNFα-
induced degradation, suggesting that SUMO1 functions as a direct antagonist of 
ubiquitin and ubiquitin-dependent degradation of IκBα. Unlike SUMOylation and 
ubiquitination of IκBα that target the same acceptor lysine, Zap1 appears to be 
urmylated and ubiquitinated at different lysine residues, as zap1-K871R-NES is 
still being degraded (Fig. 3-11B). 
 
4.2.3  Working model and outlook 
Zap1 is urmylated at K871 in the cytoplasm (Fig. 4-1). In contrast to the nuclear 
pool of Zap1, cytoplasmic Zap1 is highly unstable. In presence of the urmylation 
machinery, Zap1 is less prone to degradation by the UPS, but is highly 
destabilized in absence of Zap1 urmylation. Therefore, Urm1 conjugation to Zap1 
could sterically hinder the interaction of the ubiquitin conjugation machinery by 
blocking the interaction of an ubiquitin E3 ligase such as Doa10 and consequently 
obstruct the degradation of Zap1. Stabilization of urmylated Zap1 could also be 
caused indirectly, such as facilitating the nucleocytoplasmic shuttling of Zap1 (as 
implicated by Van der Veen and colleagues), which in turn leaves less Zap1 to be 
localized in the cytoplasm that might consequently be degraded by the UPS 
machinery (Van der Veen et al., 2011). Either way, Zap1 urmylation seems to be 
detrimental in stabilizing Zap1, which in turn improves ZAP1 expression and 
expression of target genes under zinc-limiting conditions. Future studies are 
needed to elucidate the mechanism on how Zap1 urmylation antagonizes Zap1 
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degradation and whether this protective mechanism of Urm1 affects additional 
Urm1-substrates. 
 
Figure 4-1. Model for the role of Zap1 urmylation. 
Cytoplasmic Zap1 is recognized by the Urm1 conjugation machinery and modified at C-terminus of Zap1 at 
K871. Unmodified or deurmylated Zap1 are ubiquitinated at the C-terminus of Zap1 and consequently 
degraded by the UPS. On the other hand, Zap1 modification by Urm1 sterically hinders the binding of the 
ubiquitination machinery to Zap1. Conversely, urmylated Zap1 inhibits Zap1 ubiquitination and is therefore 
resistant to the targeting and consequent degradation via the ubiquitin-proteasome system.  
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5  Materials and methods 
5.1  Materials 
5.1.1  Chemicals and reagents 
Unless otherwise mentioned, chemicals and reagents were obtained from Abcam, 
Applied Biosystems, Becton Dickinson, Biomol, Biorad, Biozym, Carl Roth, 
Chromotek, GE Healthcare, Invitrogen, Merck, New England Biolabs, Promega, 
Roche or Sigma-Aldrich. For all the methods described, sterile solutions, sterile 
flasks and deionized water were used.  
 
 
5.1.2  Antibodies 
The following antibodies were used for protein detection by immunoblotting, for 
intracellular localization studies by immunofluorescence microscopy and for 
studying protein-protein interactions by immunoprecipitation. 
 
Primary antibodies Source 
Monoclonal anti-c-myc (9E10) 
Polyclonal anti-c-myc (A-14) 
Monoclonal anti-Dpm1 
Monoclonal anti-GFP (B-2) 
Monoclonal anti-HA (F-7) 
Polyclonal anti-HA (Y-11) 
Monoclonal anti-Pgk1 
Polyclonal anti-Urm1 
Santa Cruz 
Santa Cruz 
Invitrogen 
Santa Cruz 
Santa Cruz 
Santa Cruz 
Invitrogen 
This study 
Secondary antibodies  
HRP-coupled anti-mouse IgG 
HRP-coupled anti-rabbit IgG 
Alexa Fluor 488 anti-rabbit IgG 
Dianova 
Dianova 
Molecular Probes 
 
 
5.2  Microbiological and genetic techniques 
5.2.1  E. coli  techniques  
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E. col i  strains 
Strain name Genotype Source 
Rosetta (DE3) F- ompT hsdSB(rB- mB-) gal dcm (DE3) pRARE (CamR) Novagen 
Rosetta 2 F– ompT hsdSB(rB- mB-) gal dcm lacY1 pRARE (CamR) Novagen 
Stellar F–, endA1, supE44, thi-1, recA1, relA1, gyrA96, phoA, 
Φ80d lacZΔ M15, Δ (lacZYA - argF) U169, Δ (mrr - 
hsdRMS - mcrBC), ΔmcrA, λ– 
Clontech 
XL1-Blue 
 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac 
[F´ proAB lacIq Z∆M15 Tn10 (Tetr)] 
 
Stratagene 
 
 
E. col i  vectors 
Vector name Epitope tag 
Selection 
marker  Source 
pGEX-4T1 GST ampicillin  Sigma-Aldrich 
pQE30 6xHis ampicillin  Clontech 
 
E. coli  media  
LB-medium/[plates] 1% (w/v) tryptone peptone 
 0.5% (w/v) yeast extract 
 0.5% (w/v) NaCl 
 [2% (w/v) agar] 
 adjust volume with ddH2O 
 sterilize by autoclaving 
  
optional: add antibiotics after autoclaving and cooling down to 60°C. 
 
SOB 2.5% (w/v) tryptone peptone 
 0.625% (w/v) yeast extract 
 10 mM NaCl 
 2.5 mM KCl 
 adjust volume with ddH2O 
 10 mM MgCl2 and 10 mM MgSO4 
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SOC SOB containing 10 mM glucose 
 
Transformation buffer 1 (TB 1) 10 mM MOPS, pH 6.5 
adjusted with KOH 
 100 mM KCl 
 45 mM MnCl2 
 10 mM CaCl2 
 10 mM KAc, pH 7.5 adjusted with HCl 
 adjust volume with ddH2O 
 
Transformation buffer 2 (TB 2) TB 1 with 10% glycerol 
 
Transformation buffer 3 (TB 3) 100 mM CaCl2 
 50 mM MgCl2 
  
Cult ivation and storage of E. coli  
Liquid cultures were grown on LB media at 37°C (or at 25°C for recombinant 
protein expression) with constant shaking. Cells grown on agar plates were 
incubated at 37°C. Bacteria transformed with plasmid DNA were grown on media 
containing the appropriate antibiotic (50 μg/ml ampicillin and 50 μg/ml kanamycin). 
The cell culture density was determined by measuring the absorbance at a 
wavelength of 600 nm (OD600). Cultures were either stored temporarily at 4°C or 
were put in 15% (v/v) glycerol solution at -80°C for long-term storage. 
 
Preparation of chemically competent E. coli  
Fresh cells were streaked out from a frozen glycerol stock on a LB agar plate and 
grown overnight. A single colony was picked and incubated in 5 ml LB medium 
overnight. 2 ml of the overnight culture was inoculated in 200 ml pre-warmed SOB 
and grown to ~0.5 OD600. The culture was then cooled on ice for 10 min were 
harvested by centrifugation (10 min, 2500 rpm, 4°C). The cell pellet was 
resuspended in 100 ml TB 1 and cooled on ice for 10 min. The resuspended cells 
were pelleted by centrifugation and resuspended in a solution containing 16 ml TB 
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2 and 560 μl DMSO and incubated on ice for 15 min. Finally, the competent cells 
were stored in 150 μl aliquots at -80°C. 
Transformation of plasmid DNA into competent E. coli 
Competent E. coli cells were thawed on ice and 50 μl of chemically competent 
cells were mixed with 10 ng plasmid DNA. Subsequently, the solution was 
incubated on ice for 30 min, incubated at 42°C for 45 s. After the heat shock, the 
cells were incubated on ice for 2 min and were incubated in 1 ml LB at 37°C for 
30-45 min under constant shaking. The transformed cells were harvested (3 min, 
800 g, room temperature), plated on ampicillin-containing LB agar plates and 
incubated overnight at 37°C. 
 
Recombinant protein expression in E. coli  
For the expression recombinant proteins in E. coli, competent Rosetta (DE3) and 
Rosetta 2 were used. Cells transformed with the desired plasmid DNA were 
directly transferred and incubated in 25 ml LB medium containing the appropriate 
antibiotic overnight at 37°C. The overnight culture was transferred to 1 l ampicillin-
containing LB medium. Once the cells reach 0.6 OD, the protein expression was 
induced by the addition of 0.5 M IPTG for at least 4 h at 25°C. Lastly, the cells 
were harvested by centrifugation (5 min, 800 g, 4°C) and stored in -80°C. 
 
5.2.2  S. cerevisiae  techniques 
S. cerevisiae strains 
Strain 
name Genotype Reference 
DF5 MATa 
(WT) MATa his3-200, LEU2-3, 2-112, lys2-801, trp1-1, ura3-52 (Finley et al., 1987) 
IP541 MATa lys1::natNT2 arg4::hphNT1 I. Psakhye 
W303 MATa eu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 E. Schwob, K. Nasymth 
PJ69-7a MATa trp1-901 LEU2-3,112 ura3-53 his3-200 gal4 gal80 GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ Warf 
RH448a MATa LEU2 his4 lys2 ura3 bar1-1 M. Knop 
RC757α MATα his6 met1 sst2-1 cyh2 can1 M. Knop 
ySL_333 DF5, MATa pCYC1-GFP-zap1-C::LEU2 this work 
ySL_334 DF5, MATa urm1::natNT2 pADH1-6His-Strep-URM1-tADH::URA3 pCYC1-GFP-zap1-C::LEU2 this work 
ySL_335 DF5, MATa uba4::kanMX6 urm1::natNT2 pADH1-6His-Strep-URM1-tADH::URA3 pCYC1-GFP-zap1-C::LEU2 this work 
ySL_336 DF5, MATa urm1::natNT2 pCYC1-GFP-zap1-C::LEU2 this work 
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ySL_337 DF5, MATa uba4::kanMX6 urm1::natNT2 pCYC1-GFP-zap1-C::LEU2 this work 
ySL_010 DF5, MATa lys1::natNT2 arg4::hphNT1 uba4::HIS3MX6 urm1::kanMX6 pADH1-6His-3HA-URM1L96R-tADH::URA3 this work 
ySL_018 DF5, MATa lys1::natNT2 arg4::hphNT1 urm1::kanMX6 pADH1-6His-Strep-URM1-tADH::URA3 this work 
ySL_021 DF5, MATa urm1::natNT2 pADH1-6His-Strep-URM1-tADH::URA3 this work 
ySL_022 DF5, MATa lys1::natNT2 arg4::hphNT1 urm1::natNT2 pADH1-6His-Strep-URM1-L96R-tADH::URA3 this work 
ySL_026 DF5, MATa ZAP1-6HA::klTRP1 this work 
ySL_030 DF5, MATa uba4::kanMX6 urm1::natNT2 pADH1-6His-Strep-URM1-tADH::URA3 ZAP1-6HA::klTRP1 this work 
ySL_031 DF5, MATa urm1::natNT2 pADH1-6His-Strep-URM1-tADH::URA3 ZAP1-6HA::klTRP1 this work 
ySL_061 DF5, MATa ZRT1-3myc::klTRP1 this work 
ySL_062 DF5, MATa ZRT1-3myc::klTRP1 urm1::natNT2 this work 
ySL_063 DF5, MATa uba4::kanMX6 urm1::natNT2 pADH1-6HisFlag-URM1 tADH::URA3 ZRT1-3myc::klTRP1 this work 
ySL_065 DF5, MATa urm1::kanMX6 zap1-K871R-6HA:TRP this work 
ySL_073 DF5, MATa zap1::hphNT1 this work 
ySL_075 DF5, MATa urm1::natNT2 pADH1-6His-Strep-URM1-tADH::URA3 zap1-K871R-6HA::klTRP1 this work 
ySL_081 DF5, MATa uba4::kanMX6 ZAP1-6HA::klTRP1 this work 
ySL_105 DF5, MATa urm1::natNT2 zap1::hphNT1 this work 
ySL_105 DF5, MATa urm1::natNT2 zap1::hphNT1NT1 this work 
ySL_107 DF5, MATa ZAP1-GFP::klTRP1 this work 
ySL_117 DF5, MATa pMET25-GFP-zap1-C::URA3 this work 
ySL_132 DF5, MATa pMET25-GFP-zap1-C-K871R::URA3 this work 
ySL_249 DF5, MATa ZAP1-urm1ΔGG-6His-3HA::LEU2 this work 
ySL_250 DF5, MATa zap1-K871R-urm1ΔGG-6His-3HA::LEU2 this work 
ySL_251 DF5, MATa ZAP1-urm1ΔGG-6His-3HA::LEU2 urm1::natNT2 this work 
ySL_252 DF5, MATa ZAP1-urm1ΔGG-6His-3HA::LEU2 uba4::kanMX6 this work 
ySL_255 DF5, MATa zap1-K871R-6HA::klTRP1 this work 
ySL_256 DF5, MATa pCYC1-ZAP1-6HA::LEU2 this work 
ySL_259 DF5, MATa pCYC1-zap1-AD2-6HA::LEU2 this work 
ySL_260 DF5, MATa urm1::natNT2 pADH1-6His-Strep-URM1-tADH::URA3 pCYC1-zap1-AD2 6HA::LEU2 this work 
ySL_262 DF5, MATa pCYC1-zap1-DBD-6HA::LEU2 this work 
ySL_263 DF5, MATa urm1::natNT2 pADH1-6His-Strep-URM1-tADH::URA3 pCYC1-zap1-DBD 6HA::LEU2 this work 
ySL_274 DF5, MATa uba4::kanMX6 pCYC1-ZAP1-6HA::klTRP1 this work 
ySL_363 DF5, MATa pCYC1-GFP-zap1-C K877R::LEU2 this work 
ySL_364 DF5, MATa urm1::natNT2 pADH1-6His-Strep-URM1-tADH::URA3 pCYC1-GFP-zap1-C-K877R::LEU2 this work 
ySL_365 DF5, MATa pCYC1-GFP-zap1-C-K871R::LEU2 this work 
ySL_366 DF5, MATa urm1::natNT2 pADH1-6His-Strep-URM1-tADH::URA3 pCYC1-GFP-zap1-C-K871R::LEU2 this work 
ySL_367 DF5, MATa pCYC1-GFP-zap1-C-C872S::LEU2 this work 
ySL_368 DF5, MATa urm1::natNT2 pADH1-6His-Strep-URM1-tADH::URA3 pCYC1-GFP-zap1-C-C872S::LEU2 this work 
ySL_415 DF5, MATa pCYC1-GFP-zap1-C-NLS::LEU2 this work 
ySL_416 DF5, MATa urm1::natNT2 pADH1-6His-Strep-URM1-tADH::URA3 pCYC1-GFP-zap1-C-NLS::LEU2 this work 
ySL_417 DF5, MATa pCYC1-GFP-zap1-C-NES::LEU2 this work 
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ySL_418 DF5, MATa urm1::natNT2 pADH1-6His-Strep-URM1-tADH::URA3 pCYC1-GFP-zap1-C-NES::LEU2 this work 
ySL_419 DF5, MATa pCYC1-GFP-zap1-C-K871R-NLS::LEU2 this work 
ySL_420 DF5, MATa urm1::natNT2 pADH1-6His-Strep-URM1-tADH::URA3 pCYC1-GFP-zap1-C-K871R-NLS::LEU2 this work 
ySL_421 DF5, MATa pCYC1-GFP-zap1-C-K871R-NES::LEU2 this work 
ySL_422 DF5, MATa urm1::natNT2 pADH1-6His-Strep-URM1-tADH::URA3 pCYC1-GFP-zap1-C-K871R-NES::LEU2 this work 
ySL_441 DF5, MATa urm1::natNT2 pCYC1-GFP-zap1-C-NLS::LEU2 this work 
ySL_443 DF5, MATa urm1::natNT2 pCYC1-GFP-zap1-C-NES::LEU2 this work 
ySL_445 DF5, MATa uba4::kanMX6 pCYC1-GFP-zap1-C-NLS::LEU2 this work 
ySL_447 DF5, MATa uba4::kanMX6 pCYC1-GFP-zap1-C-NES::LEU2 this work 
ySL_452 DF5, MATa pCYC1-GFP::LEU2 this work 
ySL_455 DF5, MATa pCYC1-GFP-zap1-C::LEU2 this work 
ySL_457 DF5, MATa uba4::kanMX6 pCYC1-GFP-zap1-C::LEU2 this work 
ySL_458 DF5, MATa pCYC1-GFP-zap1-C-K871R::LEU2 this work 
ySL_476 DF5, MATa cim3-1 pdr5::HIS3MX6 pCYC1-GFP-zap1-C::LEU2 this work 
ySL_508 DF5, MATa cim3-1 urm1::natNT2 Zap1-HA6::TRP this work 
ySL_510 DF5, MATa cim3-1 pCYC1-Zap1-HA6::TRP this work 
ySL_521 DF5, MATa natNT2::pGAL1-Urm1 pCYC1-Zap1-6HA::LEU2 this work 
ySL_524 DF5, MATa doa10::kanMX6 pCYC1-GFP-zap1-C-NES::LEU2 this work 
ySL_525 DF5, MATa doa10::kanMX6 pCYC1-Zap1-6HA::LEU2 this work 
ySL_526 DF5, MATa cdc48-3 pCYC1-GFP-zap1-C-NES::LEU2 this work 
ySL_527 DF5, MATa cdc48-3 pCYC1-ZAP1-6HA::LEU2 this work 
 
S. cerevisiae vectors 
Plasmid type Name (marker) Copies/Cell  Reference 
Integrative 
YIplac211 (URA3) 
1 Gietz and Sugino, 1988 YIplac128 (LEU2) 
2μ pUG36 (URA3) 50-100 J. H. Hegemann  
Yeast two-hybrid 
pGAD-C1-3 
pGBD-C1-3 
50-100 James et al., 1996 
 
S. cerevisiae media and solutions 
YPD/YPR/YPG [plates] 1% yeast extract 
 2% bacto-peptone 
 2% carbon source (glucose, raffinose or 
galactose) 
 [2% agar] sterilized by autoclaving 
 
 For selection plates: YPD medium with 2% agar was 
cooled to 60°C and the respective selection drug was added. 
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 200 mg/l geneticine disulphate (G418) 
 100 mg/l nourseothricin (NAT) 
 500 mg/l hygromycin B (Hph) 
  
amino acid drop out mix 800 mg adenine 
 800 mg uracil 
 800 mg tryptophan 
 800 mg histidine 
 800 mg arginine 
 800 mg methionine 
 1200 mg tyrosine 
 2400 mg leucine 
 1200 mg lysine 
 2000 mg phenylalanine 
 8000 mg threonine 
 
optional: 1200 mg isoleucine 
 6000 mg valine 
 4000 mg aspartic acid 
 
SC-medium/[plates] 0.67% yeast nitrogen base 
 0.2% amino acid drop out mix 
 2% carbon source (glucose, raffinose or 
galactose) 
 [2% agar] sterilized by autoclaving 
 
low zinc medium (LZM) 2x SC 
 20 mM sodium citrate, pH 4.2 
 1 mM EDTA 
 2% glucose 
 adjust volume with ddH2O 
 sterilized by sterile filtration 
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sporulation medium 2% (w/v) potassium acetate, sterilized by autoclaving 
zymolyase 100T solution 0.9 M sorbitol 
 0.1 M Tris-HCl, pH 8.0 
 0.2 M EDTA, pH 8.0 
 50 mM DTT 
 0.5 mg/ml zymolyase 100T 
SORB 100 mM LiOAc 
 10 mM Tris-HCl, pH 8.0 
 1 mM EDTA, pH 8.0 
 1 M  sorbitol 
 sterilized by filtration 
 
PEG 100 mM LiOAc 
 10 mM Tris-HCl, pH 8.0 
 1 mM EDTA, pH 8.0 
 40% (w/v) PEG-3350 
 sterilized by filtration 
 
Cult ivation and storage of S. cerevisiae 
In general, a fresh single yeast colony was inoculated in YP or SC based medium 
at 30°C (25°C with heat sensitive strains) overnight. Overnight cultures were 
generally diluted to 0.1 OD600 in a new flask containing fresh medium. Yeast cells 
were then grown at 30°C under constant shaking until they reach the mid-log 
phase (OD600 0.6-0.9). Cultures on grown on YP or SC based agar plates were 
stored at 4°C up to 1-2 months. Conversely, stationary cultures were stored in 
15% (v/v) glycerol solutions at -80°C for long-term storage. 
 
Preparations of competent yeast cells 
Mid-log phase growing yeast cells were harvested by centrifugation (500 g, 5 min, 
room temperature), washed with ½ volume of sterile ddH2O and lastly washed with 
1/10 volume SORB. The cells were pelleted again and resuspended in 360 μl 
MATERIAL AND METHODS 
 
 62 
SORB and 50 μl denatured carrier DNA. The competent cells were stored at -
80°C. 
 
Transformation of yeast cells 
200 ng of circular or 2 μg of linearized plasmid DNA/PCR product was added to 10 
μl or 50 μl competent yeast cells, respectively. Six volumes of PEG were added, 
mixed thoroughly and the cell suspension was incubated at room temperature for 
30 min. A final concentration of 10% DMSO was added to the solution prior to 
heat-shocking the cells at 42°C for 10-20 min. Cells were pelleted by centrifugation 
(500 g, 3 min, room temperature) and resuspended in 200 μl sterile ddH2O. If the 
transformed DNA contains an auxotrophic genetic marker, the transformed cells 
were directly plated on their respective SC agar plates. For transformed DNA that 
contain antibiotic resistance markers, transformed cells were incubated for 1-2h in 
2 ml liquid YPD medium at 30°C (25°C for heat sensitive strains) prior to plating.  
 
Genomic manipulation by homologous recombination 
Integration of DNA into yeast genome was either achieved by introducing a 
linearized integrative vector or by transforming a PCR DNA fragment in yeast cells. 
The integrative yeast vectors of the YIplac vector series were used in this study, 
since they do not contain autonomous replication elements. Consequently, only 
stably integrated vectors are propagated in yeast. Prior to transformation, YIplac 
vectors were linearized within their respective auxotrophic markers by introducing 
a single cut using restriction enzymes. Linearized YIplac plasmids were then 
integrated into the yeast genome by homologous recombination with the 
endogenous marker gene. 
Deletions, truncations, N-/C-terminal tags, point mutants or fusions were generally 
introduced by employing a PCR-based strategy, which ensures stable integration 
into the yeast genome by homologous recombination (Longtine et al. 1998, Knop 
et al., 1999, Janke et al., 2004). For this approach, the PCR products consisted of 
a selection marker gene and were additionally flanked by 45-55 bp sequences that 
were homologous to the target sequence. The desired DNA fragments were 
amplified by PCR, purified using the QIAquick purification PCR kit, transformed 
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into competent yeast cells and plated on the respective selection medium. The 
correct recombination event was confirmed by yeast colony PCR. 
 
PCR reaction mixture  100 ng plasmid DNA 
    30 μl 10x ThermoPol reaction buffer (NEB) 
 10.5 μl dNTP-Mix (10 mM each, NEB) 
 19.2 μl forward primer (100 μM) 
 19.2 μl reverse primer (100 μM) 
   2.4 μl Taq DNA polymerase 
   2.1 μl Vent DNA polymerase (NEB) 
 adjust to a total volume of 300 μl with ddH2O 
 
Cycling parameters  
PCR step T [°C] Time Cycles 
Initial denaturation 95/97 3 min 1 
Denaturation 94 30 s/1 min 
10 Annealing 54 30 s 
68 72 2 min 40 s 
Denaturation 95/97 30 s 
20 Annealing 54 30 s/1 min 
68 68 2 min 40 s (+20 s/cycle) 
Final elongation 68 10 min 
1 
Cooling 4 ∞ 
Grey: conditions for the amplification of all natNT2-based cassettes 
 
Yeast colony PCR 
Genomic alterations such as insertions, deletions, truncations and mutations were 
identified by the PCR-based yeast colony strategy. A fresh single yeast colony 
was transferred into a safe-lock reaction tube that contained 20 µl 0.02 M NaOH 
and acid-washed glass beads (Sigma). The yeast cells were lysed at 95°C for 5 
min under vigorous shaking (1400 rpm) and the cell debris was pelleted by 
centrifugation (16.000 g, 1 min, RT). The supernatant was transferred to a PCR 
reaction tube and was used as PCR template. Two DNA oligonucleotides were 
used for the yeast colony PCR that were able to prime upstream/downstream of 
the altered chromosomal locus (primer 1) as well as within the integrated selection 
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marker gene (primer 2). The yeast colony PCR was carried out using the PCR 
reaction mixture and the cycling parameters as described below. 
 
PCR reaction mixture     4.0 μl yeast solution (template) 
     5.0 μl 10x ThermoPol reaction buffer (NEB) 
   1.75 μl dNTP Mix (10 mM each, Thermo Fisher 
Scientific) 
     3.2 μl primer 1 (10 μM) 
     3.2 μl primer 2 (10 μM) 
        1 μl 50 mM MgCl2 
     0.4 μl Taq DNA polymerase 
 32.45 μl ddH2O 
 
Cycling parameters  
PCR step T [°C] Time Cycles 
Initial denaturation 94 5 min 1 
Denaturation 94 30 s 
30 Annealing 55 30 s 
Elongation 72 1 min/kb 
Final elongation 72 15 min 
1 
Cooling 4 ∞ 
 
Mating of haploid S. cerevisiae  strains 
Equal amounts of freshly streaked haploid yeast strains of opposite mating type 
(MATa, MATα) were mixed in 500 μl YPD and incubated at 30°C overnight under 
constant shaking (200 rpm). Cells were sedimented by centrifugation (500 g, 5 
min, RT), resuspended in 100 μl H2O and plated on respective selection plates to 
select diploid cells. 
 
Sporulation and tetrad dissection of diploid yeast strains 
Fresh diploid colonies were first incubated in 5 ml YPD at 30°C overnight. 800 μl 
of the overnight culture was harvested by centrifugation (500 g, 5 min, RT), 
washed four times in 1 ml sporulation medium and incubated in 4 ml sporulation 
medium at RT for 3-7 days. 10 μl of the culture was mixed with 10 μl zymolyase 
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100T solution and incubated at RT for 10 min. This mixture was subsequently 
applied on pre-warmed YPD agar plates, dissected with a micromanipulator 
(Singer MSM Systems) and grown on YPD plates for 3-3 days at 30°C. Lastly, the 
tetrads were genotypically examined either by replica plating the cells on selection 
plates or by their phenotype. 
 
Mating-type analysis of haploid yeast strains 
The mating type analysis utilizes the tester strains RC757α and RH448a to identify 
yeast mating-types, since these strains are hypersensitive to the mating 
pheromones secreted by both MATa and MATα strains. As a result, tester strains 
were not able to grow in the proximity of haploid cells with opposite mating type. 
Consequently, a halo was formed surrounding the replica-plated colony, if said 
strain displayed the opposite mating type as the tester strain. In principle, the 
tester strain were resuspended in 50 μl of ddH2O and mixed with 10 ml of 
lukewarm YPD containing 1% (w/v) molten agar. The mixture was poured over 
YPD agar plates. Next, the tetrads were replica plated on the a- and α-tester agar 
plates and incubated for at 30°C for one or two days.  
 
Analysis of protein-protein interaction using the yeast two-hybrid 
system (Y2H)  
The two-hybrid system was used to identify novel protein-protein interactions in 
the yeast. Protein-protein interactions were determined by using fusion proteins 
containing the bait protein fused to the DNA-binding domain (BD) and the prey 
protein that was fused to the activation domain (AD) of the Gal4 transcription 
factor. In case the bait interacted with the prey protein, Gal4 BD and AD were 
brought in proximity, resulting in the reconstitution of a functional Gal4 transcription 
factor. Essentially, Y2H-specific yeast strains were used which lacked the 
transcription factor Gal4 and contained the reporter genes GAL1-HIS3 and GAL2-
ADE2 that only showed gene expression in presence of a functional Gal4. Initially, 
full-length ORFs, fragments or mutant variants of proteins were fused to the C-
terminus of either the BD or AD of the Gal4 transcription factor and the fusion ORF 
was inserted into the expression vectors pGBD-C1 and pGAD-C1, respectively. 
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The plasmids were transformed into competent PJ69-7a cells (Warf) and streaked 
on SC –Leu –Trp plates at 30°C for 3-3 days. Protein-protein interactions were 
tested by growing the transformed Y2H strains on SC –Leu –Trp –His and/or on 
SC –Leu –Trp –Ade agar plates. 
 
Phenotypic analysis of S. cerevisiae mutant variants using growth 
assays 
A canonical way to analyze phenotypes of yeast mutant variants was to compare 
their growth rates with other strains under optimal and suboptimal conditions (e.g. 
environmental, chemical stressors, etc.). Overnight cultures were harvested during 
the mid-log growth phase and washed once with 1 ml ddH2O. A total of 0.5 OD 
yeast cells (ad 250 μl ddH2O) were transferred to a 96-well microtiter plate. After 
four to five 1:5 serial dilutions, the cells were spotted onto the respective agar 
plates using a sterile 96-pin stamp. Finally, the growth phenotypes of the mutant 
variants were incubated for several days at different temperatures. 
 
Analysis of protein stabil i ty using the cycloheximide chase assay 
The protein stability was determined by the cycloheximide chase assay. 
Cycloheximide is a potent eukaryotic protein synthesis inhibitor that immediately 
stops de novo protein synthesis, which in turn permitted the study of protein 
degradation over time. Essentially, cells were grown to mid-log phase, harvested 
by centrifugation (500 g, 5 min, RT) and resuspended in growth medium 
containing 150 μg/ml of cycloheximide. For each time point, 1 OD of cells were 
harvested (16.000 g, 1 min, RT) and immediately frozen in liquid nitrogen. Finally, 
protein extracts were prepared and the protein turnover for the protein of interest 
was determined by western blotting. 
 
Microsomal preparation 
To isolate microsomal fractions, 20 OD log phased cells were sedimented by 
centrifugation (500 g, 5 min, 4°C), washed once with ice-cold water and 
resuspended in 1 ml lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM 
EDTA, pH 8.0, EDTA-free protease inhibitors (Roche)). Zirconia/silica beads (ø 0.5 
MATERIAL AND METHODS 
 
 67 
mm, Carl Roth) were added to the cell suspension and the cells were lysed using a 
multi-tube bead-beater (3x 30 Hz, 1 min, 5 min cooling intervals, 4°C, MM301 
Retsch). The reaction tubes containing the cell lysates were perforated with a 
heated syringe needle and piggybacked into a fresh reaction tube (500 g, 2 min, 
4°C). Cell debris was removed by centrifugation (500 g, 10 min, 4°C). The total cell 
extract (T) contains the soluble fraction (S, cytosolic and nuclear proteins) and the 
microsomes (P, ER, nuclear envelope and golgi apparatus). To separate the 
soluble fraction from the microsomal fraction, whole cell extracts were transferred 
into ultracentrifuge-compatible reaction tubes (microfuge tube polyallomer, 
Beckman Coulter) and fractionated by ultracentrifugation (100.000 g, 30 min, 4°C, 
TLA 55 rotor).  
 
Membrane fractionation 
To investigate whether the proteins found in the microsomal fraction were either 
membrane-associated or peripheral membrane proteins, microsomes were 
enriched as described in microsomal preparation. Microsomal fractions were 
divided in equal parts and resuspended in lysis buffer either containing 1 M 
Na2CO3, pH 11.3, 500 mM NaCl or 1% SDS. The samples were incubated on ice 
for 30 min with occasional vortexing and then centrifuged (20.000 g, 30 min, 4°C). 
After the removal of the supernatant, the pellets were resolubilized in SDS-PAGE 
sample buffer and analyzed by immunoblotting. 
 
Semi-denaturing purif ication of ubiquitylated GFP-tagged proteins 
To examine ubiquitylated GFP-tagged proteins, 50-200 OD of mid-log phased 
yeast cells were harvested, lysed by cryogenic grinding and resuspended in lysis 
buffer (3x volume to 1x OD, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 
0.5% Triton X-100, PIC, 10 mM NEM). The cell lysates were piggybacked (500 g, 
2 min) to fresh reaction tubes in which the cell debris was sedimented by two 
centrifugation steps (2655 g, 5 min, 4°C and 15.700 g, 5 min, 4°C). 15 μl pre-
equilibrated GFP agarose beads (GFP-Trap_A, Chromotek) were added to the 
cleared supernatant and incubated for 150 min at 4°C. After removing the 
supernatant (100 g, 2 min, RT), the beads were washed once with dilution buffer 
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(10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5 mM EDTA, PIC, 10 mM NEM), thrice 
with wash buffer 1 (PBS, 8 M urea, 1% SDS) and once with wash buffer 2 (PBS, 
1% SDS). The specifically bound proteins were eluted from the agarose beads by 
the addition of 20 μl SDS-PAGE sample buffer and analyzed by immunoblotting. 
 
Yeast indirect immunofluorescence 
Protein subcellular localization was studied by immunofluorescence microscopy. 
Yeast cells were grown to mid-log phase in SC medium and were fixed by adding 
a formaldehyde solution (total concentration 0.1 M KPO4, 4% formaldehyde) to the 
culture. Cells were incubated for 1h at RT, harvested by centrifugation (500 g, 5 
min, 4°C) and washed three times with 1 ml SP buffer (0.1 M KPO4, pH 6.5, 1.2 M 
sorbitol). Yeast cells were resuspended in 0.9 ml SPβ buffer (SP containing 20 
mM β-mercaptoethanol) and 0.1 ml Zymolyase 100T solution (2.5 mg/ml in SPβ 
buffer). After an incubation period of 15 to 45 min at 30°C, yeast cell walls were 
digested. Spheroplasts were kept on ice for 5 min, washed three times with 1 ml 
cold SP buffer (1.500 g, 5 min) and seeded on polylysine-coated multi-well slides. 
Cells were permeabilized with methanol (-20°C) for 5 min, followed by incubation 
with acetone (-20°C) for 30 s. Multi-well slides were air dried for 5 min at room 
temperature. To prevent unspecific binding of the antibodies, 20 μl of PBS-B (50 
mM NaPO4, 150 mM NaCl, pH 7.5, 1% BSA) were added for each multi-slide well 
and incubated for 1 h at RT. A primary antibody was added (polyclonal rabbit anti-
HA Y-11, 1:100 in PBS-B) to each multi-well slide and incubated in a moist 
chamber at 4°C. Afterwards, cells were washed six times with PBS-B and the 
fluorescence-labeled secondary antibody (Alexa Fluor 488 goat anti-rabbit IgG) 
was added for 2 h at RT in a moist chamber. Slides were washed five times with 
PBS-B and once with PBS-B containing DAPI (0.25 μg/ml DAPI in PBS). The 
solution was incubated for 30 min at RT in the dark and consequently air dried for 
5 min at RT. Finally, a drop of mounting medium (Vectashield, Vector 
Laboratories) was applied at each well, slides were then covered by a cover slip 
and lastly sealed with nail polish. Multi-well slides could now be examined under a 
fluorescence microscope. 
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5.2.3  Molecular biological techniques 
General buffers and solutions 
 
HU sample buffer 8 M  urea 
 5%  SDS 
 1 mM  EDTA 
 1.5%  DTT 
 0.04%  bromophenol blue 
 
4x SDS sample buffer 0.25 M  Tris-HCl, pH 6.8 
 8%  SDS 
 40%  glycerol 
 0.04%  bromophenol blue 
 5%  β-mercaptoethanol 
 
MOPS buffer 50 mM  MOPS 
 50 mM  Tris base 
 3.5 mM  SDS 
 1 mM  EDTA 
 
Transfer buffer 250 mM  Tris base 
 1.92 M  glycine 
 0.1%  SDS 
 20%  methanol 
 
TBS-T 50 mM  Tris-HCl, pH 7.6 
 150 mM  NaCl 
 0.1%  Tween 20 
 
TBE buffer 10x 1 M Tris 
 1 M boric acid 
 0.02 M EDTA 
MATERIAL AND METHODS 
 
 70 
 
DNA loading buffer 5x 0.5% (w/v) SDS 
 0.1 M EDTA, pH 8.0 
 25% glycerol 
 0.25% (w/v) orange G 
 
 
Isolation of plasmid DNA from E. coli 
A single E. coli colony containing the DNA plasmid of interest was inoculated in 5 
ml LB medium and incubated for 8-14 h at 37°C under constant shaking. Plasmid 
preparation kits were used to extract plasmids (Qiaprep Spin Miniprep, Qiagen 
and AccuPrep Plasmid Mini Extraction Kit, Bioneer). 
 
Isolation of chromosomal DNA from S. cerevisiae  
To extract chromosomal DNA from S. cerevisiae, a yeast DNA purification kit 
(MasterPure yeast DNA purification, Epicentre) was used. Usually, a total of 1.5 ml 
overnight yeast culture was used for the chromosomal yeast DNA isolation. 
 
Determining DNA concentration 
The DNA concentration was determined by measuring the absorbance at the 
wavelengths of 260 nm and 280 nm (NanoDrop 1000, Thermo Scientific). 
 
Agarose gel electrophoresis 
DNA samples were resuspended with 5x DNA loading buffer, loaded into pockets 
of 0.7 – 2% agarose gels that contained 0.5 μg/ml ethidium bromide and subjected 
to gel electrophoresis at 100 V in TBE buffer. A DNA ladder (1 kb Plus DNA 
ladder, Invitrogen) was used as a size reference. DNA fragments were visualized 
under UV light. 
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DNA sequencing 
The MPIB core facility and Eurofins Genomics performed all sequencing reaction. 
The sample concentration usually consisted of 50 - 100 ng/μl for plasmid DNA or 1 
– 10 ng/μl for PCR products. 
 
Molecular cloning 
Primers that were used for cloning generally consisted of a leader sequence, a 
restriction site and lastly a hybridization sequence, which was complementary to 
the template DNA. Generally, a high-fidelity DNA-polymerase (Phusion high-fidelity 
polymerase, New England Biolabs) was used for PCR-based DNA amplification. 
The following PCR reaction setup was used: 
 
PCR reaction mixture 50-250 ng template DNA 
         10 μl 5x Phusion HF buffer 
           1 μl dNTP Mix (10 mM each, Thermo Fisher 
Scientific) 
           3 μl primer 1 (10 μM) 
           3 μl primer 2 (10 μM) 
        0.5 μl Phusion DNA polymerase 
      31.5 μl ddH2O 
 
Cycling parameters  
PCR step T [°C] Time Cycles 
Initial denaturation 98 1 min 1 
Denaturation 98 30 s 
30 Annealing 55 30 s 
Elongation 72 30 s /kb 
Final elongation 72 7 min 
1 
Cooling 4 ∞ 
 
 
PCR products were isolated by gel extraction and were purified by a gel extraction 
kit (QIAquick gel extraction kit, Qiagen). The PCR products and the vector DNA 
were sequence-specifically cleaved with their designated restriction enzymes in 
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accordance to standard protocols and manufacturer’s instructions (Sambrook et 
al., 1989 and New England Biolabs). Optionally, linearized vectors were incubated 
at 37°C for 1 h with calf intestinal alkaline phosphatase (New England Biolabs) to 
avoid re-ligation during the DNA ligation reaction. To stop enzymatic activities, 
insert DNA and linearized vectors were purified on a column (QIAquick PCR 
purification kit, Qiagen). For the ligation reaction insert vector ratio of 3:1 – 6:1 was 
used. The ligation reaction was incubated with T4-DNA ligase either for 4 h or over 
night at 16°C following the manufacturer’s instructions (New England Biolabs). 
 
Site-directed mutagenesis 
Site-directed mutagenesis was used to introduce specific DNA alterations such as 
specific substitutions, insertions or deletions in double stranded plasmid DNA 
(Kunkel, 1985). Principally, this PCR-based method utilizes two complementary 
oligonucleotide primers, containing the desired mutated nucleotide(s) with 10-15 nt 
flanking sequences complementary to the template DNA. The template plasmid 
DNA was amplified with a high-fidelity DNA polymerase (PfuUltra II Fusion HS 
DNA polymerase, Agilent).  
 
PCR reaction mixture 100 ng template DNA 
      5 μl 10x cloned Pfu reaction buffer 
   2.5 μl dNTP Mix (10 mM each, Thermo Fisher 
Scientific) 
   0.5 μl forward primer (10 μM) 
   0.5 μl reverse primer (10 μM) 
      1 μl 50 mM MgCl2 (NEB) 
   0.5 μl PfuUltra II Fusion HS DNA polymerase 
     39μl ddH2O 
 
Cycling parameters  
PCR step T [°C] Time Cycles 
Initial denaturation 95*/92** 2 min 1 
Denaturation 95*/92** 30 s 
30 
Annealing 60 30 s 
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Elongation 72*/68** 1 min/kb* 2 min/kb** 
Final elongation 72*/68** 7 min 
1 
Cooling 4 ∞ 
*<10 kb vector DNA or 
<6 kb genomic DNA 
>10 kb vector DNA or 
>6 kb genomic DNA 
 
 
Reverse transcription quantitative PCR (qRT-PCR) 
To quantify mRNA expression in yeast a two-step reverse transcription 
quantitative PCR (qRT-PCR) was applied. First, RNA was extracted from yeast 
and converted into complementary DNA (cDNA) using a reverse transcriptase. 
The newly synthesized cDNA served as a template for quantitative real-time PCR. 
In general, 2 OD of mid-log phased yeast were harvested. RNA was isolated from 
cells according to the manufacturer’s instructions (RNeasy Mini Kit, Qiagen). For 
the reverse transcription, 1 μg of total RNA was used as a template for the cDNA 
synthesis. The method was carried out according to the manufacturer’s 
instructions (Transcriptor First Strand cDNA Synthesis Kit, Roche). Thereafter, 18 
μl of qRT-PCR master mix containing SYBR Green I Master (LightCycler 480 
SYBR Green I Master), primers and H2O was added into 384 multiwell plates 
(LightCycler® 480 Multiwell Plate 384) and mixed with 2 μl of 1:5 diluted cDNA 
samples. Triplicates were made for each reaction and pipetted by a CAS-1200 
OCR setup robot (Corbett Lifescience).  
 
PCR reaction mixture   10 μl SYBR Green I Master Mix 
 0.12 μl Primer 1 (100 μM) 
 0.12 μl Primer 2 (100 μM) 
 7.76 μl ddH2O 
      2 μl cDNA PCR mix (1:5 diluted) 
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Cycling parameters  
PCR step T [°C] Time Cycles 
Initial denaturation 95 10 min 1 
Denaturation 95 10 s 
45 Annealing 55 10 s 
Elongation 72 16 s 
4°C ∞ 1 
 
Second derivative maximum method was used to quantify the template cDNA 
concentrations. As a result, an input sample dilution series for each primer pair 
was used as a standard (1:1, 1:10, 1:100 and 1:1000). Additionally, to assess the 
specificity of primer pairs, a melting curve analysis was employed after the 
amplification step.  
 
Trichloroacetic acid (TCA) protein precipitation 
Small-scale, denaturing yeast cell extracts were prepared by TCA protein 
precipitation. A total of 1 OD yeast cells was pelleted by centrifugation (16.100 g, 1 
min) and incubated in 1 ml ice-cold ddH2O with 150 μl lysis buffer (2M NaOH, 
7.5% β-mercaptoethanol) for 15 min on ice. Proteins were then precipitated by the 
addition of 150 μl 55% TCA and incubated for 15 min on ice. The precipitated 
material was sedimented by two consecutive centrifugation steps (20.000 g, 15 
min, 4°C and 16.000 g, 1 min, RT). Denatured proteins were then resuspended in 
100 μl HU sample buffer. 
 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE was performed in order to separate proteins according to their 
respective sizes. Pre-cast 4-12% gradient gels (NuPage 4-12% Bis-Tris Protein 
Gels, Invitrogen) were mainly used for this study, since these gels allowed a good 
resolution of various sized proteins (10 – 200 kDa). Protein samples were loaded 
onto the gels and separated by gel electrophoresis was carried out at a constant 
voltage of 110 V for 2 h using MOPS buffer. Protein sizes were determined by 
using a pre-stained protein standard marker (Precision Plus Protein All Blue 
Standards, Bio-Rad Laboratories). Proteins separated by SDS-PAGE were either 
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stained with Coomassie brilliant blue or transferred to a polyvinylidene fluoride 
(PVDF) membrane for immunoblotting (see Western blot analysis).  
 
Coomassie staining 
To remove SDS from SDS-PAGE gels, which inhibited the staining efficiency 
Coomassie brilliant blue, gels were washed three times with 100 ml ddH2O for 10 
minutes at RT. Proteins were subjected to an in-gel staining step by incubating it 
with a Coomassie brilliant blue solution (PageBlue protein staining solution, 
Thermo Scientific) for 1h (or overnight) at RT. Background staining was removed 
by washing the gels with 100 ml ddH2O for 20 min at RT. 
 
Western blot analysis 
Western blotting analysis utilizes specific antibodies that allow the visualization of 
target proteins. Proteins were first separated by SDS-PAGE (see above) and 
transferred onto PVDF membranes (Immobilon-P, Millipore) using a wet tank 
blotting system (TE22 Mighty Small Transfer Tank, Hoefer). Protein blotting was 
achieved in a blotting buffer containing transfer tank at a constant voltage of 70 V 
for 2 h at 4°C. PVDF membranes were initially blocked for 30 min – 1 h at RT 
using a blocking buffer (TBST with 5% skim milk powder) and consequently 
incubated with a primary antibody either for 1 h at RT or overnight at 4°C under 
constant shaking. The membrane was washed twice with TBST for 5 min at RT, 
incubated with horseradish peroxidase-conjugated secondary antibody (1:5000, 
Dianova) diluted in blocking buffer for 1-2 h at RT and washed twice times with 
TBST for 30 min at RT. Target proteins were detected by chemiluminescence 
using enhanced chemiluminescence kits (Pierce ECL Western Blotting Substrate 
and Pierce ECL 2 Western Blotting Substrate, Thermo Fisher Scientific) followed 
by exposure to light sensitive films (Amersham Hyperfilm ECL, GE Healthcare). 
Alternatively, a charged-coupled device camera (LAS-3000, Fujifilm) was used for 
chemiluminescent detection of target proteins. 
 
Purif ication of HisStrepUrm1-conjugates from denatured yeast extracts 
To identify urmylated conjugates in yeast expressing N-terminally His-tagged 
Urm1, a denatured Ni-NTA purification was carried out (Hoege et al., 2002; Sacher 
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et al., 2005). Firstly, 200 OD of log-phased cells were harvested by centrifugation 
(2500 g, 5 min, 4°C), washed with 50 ml cold PBS, transferred to a 50 ml falcon 
tube and lysed by incubating the cells with 5 ml of lysis buffer (1.85 M NaOH, 7.5% 
β-mercaptoethanol) for 15 min on ice. The cell lysate was incubated with 5 ml 55% 
TCA for 15 min on ice; precipitates were sedimented by centrifugation (8000 g, 20 
min, 4°C), washed twice with 5 ml ice-cold acetone. The pellet was air-dried for 10 
min at RT, resuspended in buffer A (6 M guanidinium chloride, 100mM NaH2PO4, 
10mM Tris-HCl, pH 8.0, 0.5% NP-40) and incubated for 1 h at RT under constant 
shaking. Insoluble aggregates were removed by centrifugation (20.000 g, 20 min, 
4°C), after which the supernatant was transferred to a fresh 15 ml falcon tube. 
Thereafter, 20 mM imidazole and 50 μl of Ni-NTA agarose beads (Qiagen) were 
added to the denatured protein extract and incubated over night at 4°C. The 
protein solution was loaded onto 5 ml a disposable polypropylene column (Qiagen) 
and the Ni-NTA agarose beads were cleared from the protein extract by gravity-
flow. Beads were washed once with 15 ml of washing buffer 1 (buffer A with 20 
mM imidazole), 15 ml of washing buffer 2 (buffer A with 20 mM imidazole, pH 6.3), 
15 ml of buffer C (8 M urea, 200 mM NaCl, 100 mM Tris-HCl, pH 6.3) with 0.5% 
NP-40 and finally with 15 ml of buffer C. HisUrm1-conjugates that were bound to 
the beads were eluted by incubation with 30 μl of SDS sample buffer at 99°C for 
10 min. Samples were subsequently subjected to SDS-PAGE and immunoblotting. 
For a His/Strep-tag tandem affinity purification of HisStrepUrm1, Urm1-conjugates 
were eluted with 15 ml elution buffer (8 M urea, 200 mM NaCl, 50 mM NaH2PO4, 
100 mM Tris-HCl, pH 6.3, 250 mM imidazole, 1% SDS) and dialyzed against PBS, 
pH 8.0 at 4°C overnight. 1 ml of strep-tactin slurry (Strep-Tactin Superflow Plus, 
Qiagen) was added to the dialyzed eluate and incubated for 4 h or overnight at 
4°C. The strep-tactin beads were washed three times with 10 bed volumes of 
PBS. Urm1-conjugates were eluted with 1 ml of 10 mM desthiobiotin, precipitated 
with 500 μl 55% TCA for 15 min on ice and sedimented by two centrifugation steps 
(20.000 g, 15 min, 4°C; 20.000 g, 1 min, RT).  Precipitates were resuspended in 
HU buffer, incubated at 65°C for 10 min and analyzed by Western blotting. 
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Purif ication of recombinant GST-tagged proteins from E. coli 
Rosetta (DE3) or Rosetta 2 cells expressing recombinant GST-tagged proteins 
were resuspended in 30-40 ml lysis buffer (1x PBS, 400 mM NaCl, 5 mM DTT, 
PIC) and disrupted by a high-pressure homogenizer (3x 40 mbar, EmulsiFlex-C3, 
Avestin). Lysates were cleared from the insoluble cell material (23.000 g, 20 min, 
4°C) and incubated with 800 μl glutathione sepharose slurry (glutathione 
sepharose 4 Fast Flow, GE Healthcare) for 2 h at 4°C. The suspension was 
loaded onto a column, which separated the resins from the cell lysate. Resins 
were washed with 0.5 l lysis buffer and eluted twice with 0.5 ml elution buffer (1x 
PBS, 400 mM NaCl, 5 mM DTT, 50 mM gluthathione, PIC). The eluate was 
dialyzed against PBS over night at 4°C, frozen in liquid N2 and stored at -80°C. For 
the tandem purification of GST-His-Flag-Urm1, GST purification was carried out as 
described above. Instead of eluting the glutathione resins with the elution buffer, 
resins were incubated with 20 U/ml thrombin at 25°C overnight. Resins were 
sedimented (500 g, 2 min, RT) and 100 μl of Ni-NTA agarose (Qiagen) were 
incubated with the supernatant for 1h at 25°C. The suspension was loaded onto a 
column, washed three times with 10 ml Ni-NTA washing buffer (PBS, 20 mM 
imidazole) and eluted with 1 ml NiNTA elution buffer (PBS, 250 mM imidazole). 
The elution was subsequently dialyzed against PBS over night at 4°C, frozen in 
liquid nitrogen and stored at -80°C. 
 
5.3  Mass spectrometry analyses 
SILAC-based mass spectrometry 
Stable isotope labeling with amino acids in cell culture (SILAC) coupled with 
MS/MS was employed to detect novel Urm1-conjugates. Auxotrophic yeast mutant 
variant strains deficient in the biosynthesis of lysine and arginine (Δlys1 Δarg4) 
expressing His- and HA-tagged Urm1 (HisHAUrm1) were grown for at least 10 cell 
divisions in SC growth media supplemented with either normal or heavy arginine 
and lysine (Arg0, Lys0; Light, Arg10, Lys8; Heavy, Cambridge Isotope Laboratories). 
Mid-log phased yeast cells grown in heavy SC media were treated with 10 mM 
NEM for 1 h at 30°C, harvested and combined with equal amount of untreated 
cells that were grown in light SC media. For label-swap replication experiments, 
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cells grown in light SC media were treated with 10 mM NEM for 1 h at 30°C, 
harvested and combined with equal amount of untreated cells grown in heavy SC 
media. HisHAUrm1-conjugates were purified using either denaturing Ni-NTA 
purification or a denaturing tandem affinity purification (see Purification of 
HisStrepUrm1-conjugates from denatured yeast extracts) and separated by SDS-
PAGE, stained with Coomassie Blue, excised in ten slices, trypsinized and 
analyzed by LC-MS/MS at the Biochemistry Core Facility of the Max-Planck 
Institute of Biochemistry using LTQ-Orbitrap mass spectrometers. Peptides of 
putative urmylated-conjugates were identified using the MaxQuant software (Cox 
and Mann, 2008). Search for Urm1 branch motif (TLHGG-ε-K, HGG-ε-K) were 
carried out either with urm1-S94R or urm1-L96R mutant variants. These mutants 
enabled trypsin-dependent cleavage of the C-terminal tail of Urm1 and 
subsequently the identification of putative urmylation sites. 
 
5.4  Computational analyses 
The Saccharomyces Genome Database (www.yeastgenome.org/) and the 
National Center for Biotechnology Information (www.ncbi.nlm.nih.gov/) were 
sources for DNA/protein sequences and scientific literature. DNA sequencing 
analyses and DNA primer design were carried out either with Lasergene 13 
(DNASTAR) or with SnapGene Viewer (SnapGene). Protein and DNA sequence 
alignment was either analyzed with BLAST (blast.ncbi.nlm.nih.gov) or with MultAlin 
(multalin.toulouse.inra.fr/multalin/). Images obtained either by microscopy or by 
Western blot quantification were carried out with ImageJ (https://imagej.nih.gov/ij/). 
Contrast of western blot films was adjusted using Adobe Photoshop CS5.1 (Adobe 
Systems). For texts, tables, graphs and figures Microsoft Office 2011 (Microsoft 
Corporation) was used. 
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7  Abbreviations 
% percent 
°C celsius 
μ  micro (x10-6) 
μg microgram 
μl microliter 
2μ  multi-copy vectors 
aa amino acid 
AAA  ATPases associated with various cellular activities 
AD  transactivation domain 
ATP  adenosine 5-triphosphate 
BD  Gal4 DNA binding domain 
bp  base pairs 
BSA  bovine serum albumin 
CCD  camera charged-coupled device camera 
cDNA  complimentary DNA 
CEN  centromeric (low copy vectors) 
CHX  cycloheximide 
C-terminal  carboxyl-terminal 
C-terminus  carboxyl terminus 
DAPI  4',6-diamidino-2-phenylindole 
DBD DNA-binding domain 
DMSO  dimethylsulfoxide 
DNA  deoxyribonucleic acid 
dNTP  deoxy nucleoside triphosphate 
DTT  dithiothreitol 
DUB  deubiquitylating 
E glutamate 
E1  ubiquitin activation enzyme 
E2  ubiquitin conjugation enzyme 
E3  ubiquitin ligase 
E4  polyubiquitylation factor 
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EDTA  ethylenediaminetetraacidic acid 
ELP elongation protein  
ER  endoplasmic reticulum 
ERAD  ER-associated degradation 
F  farad 
g  gram 
g  gravitational constant (6.6742x10-11 N m2 kg-2) 
Gal  galactosidase 
GFP green fluorescence protein 
GG double glycine 
Gln glutamine 
Glu gluatamate 
h  hour 
H2O2 hydrogen peroxide 
HA human influenza hemagglutinin 
Ig  immunoglobulin 
IP immunoprecipitation 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
K kilo (x103) 
J Joule 
K lysine 
kan  kanamycin 
kb  kilo base pairs 
kDa  kilo dalton 
LB  Luria-Bertani 
LC-MS/MS liquid chromatography tandem mass spectrometry 
Lys lysine 
LZM limited zinc medium 
M  molar 
m  milli (x10-3) 
MAT  mating type 
mcm5U34 5-methylcarboxymethyluridine modification at U34 
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min  minutes 
MoCo Molybdenum cofactor 
MOPS  3-N-Morpholinopropane sulfonic acid 
mRNA  messenger RNA 
MW  molecular weight 
MS mass spectrometry 
MS/MS tandem mass spectrometry 
n  nano (x10-9) 
NEM  N-ethylmaleimide 
NH2OH hydroxylamine 
Ni-NTA nickel−nitrilotriacetic acid 
nm nanometer 
nt nucleotide 
ADP  adenosine 5-diphosphate N-terminal amino-terminal 
N-terminal amino terminal 
N-terminus  amino terminus 
OD  optical density 
ORF  open reading frame 
PAGE  polyacrylamide gel electrophoresis 
PBS  phosphate-buffered saline 
PCR  polymerase chain reaction 
PEG  polyethylene glycol 
PIC protease inhibitor cocktail 
PMSF  phenylmethylsulphonyl fluoride 
PTM post-translational modification 
PVDF  polyvinylidene fluoride 
Q glutamine 
qRT-PCR reverse transcription quantitative PCR 
RNA  ribonucleic acid 
rpm  rounds per minute 
ROS reactive oxygen species 
RT  room temperature 
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RT-qPCR reverse transcriptase quantitative polymerase chain reaction 
RLD rhodanese-like domain 
s  seconds 
S  sedimentation coefficient (Svedberg) 
SAMP small archaeal ubiquitin-like modifier protein 
SC  synthetic complete 
SDS  sodium dodecylsulfate 
SILAC stable isotope labeling with amino acids in cell culture 
s2U34 thio-modification of U34  
SUMO small ubiquitin-like modifier 
TAP tandem affinity purification 
TBE  Tris/borate/EDTA buffer 
t-BOOH tert-butyl hydroperoxide 
TBS  Tris-buffered saline 
TCA  trichloro acidic acid 
TEMED  N,N,N’,N’-tetramethylethylenediamin 
Tris  Tris(hydroxymethyl)aminomethane 
tRNA transfer RNA 
U  unit 
U34 wobble uridine at 34th position in tRNA 
Ub  ubiquitin 
UBA  ubiquitin associated 
UBC  ubiquitin-conjugating enzyme 
UBD ubiquitin-binding domain 
UBL ubiquitin-like protein 
ULP ubiquitin-like processing enzyme 
UPS  ubiquitin/proteasome system 
Urm1 ubiquitin-related modifier 1 
UV  ultraviolet light 
V  volt 
v/v  volume per volume 
w/v  weight per volume 
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WT  wild type 
YPD  yeast bactopeptone dextrose medium 
Y2H yeast-two hybrid 
ZF zinc finger 
Zn zinc 
ZRE zinc-responsive element 
Ω  ohm
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